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It is an important goal to differentiate normal, age-related changes in joint function from changes 
associated with symptomatic pathology, surgical intervention or implant wear, fatigue or failure. A 
significant step toward this goal is the establishment of a joint-specific Patient Recorded Outcome 
Measures (PROM) reference database for individuals without joint disease, so that clinicians can 
effectively evaluate the efficacy of treatments in orthopaedic patients on a longitudinal basis. 
 
This thesis has investigated the influence of a range of factors on reported PROM values.  Factors 
assessed were age, gender, ethnicity, handedness (where applicable), nationality, history of previous 
surgery and coincident adjacent active joint pathology. No other research exists comparing multiple 
PROMs over multiple body regions within an electronic database across two continents.  
 
This thesis of 2360 participants represents the largest database reported in the literature of orthopaedic 
PROM values from asymptomatic “normal” individuals.  No other study has collated “normal” PROM 
values from multiple body regions. Nor have previous studies collected PROM scores remotely and 
electronically via the same research database, across two continents. Few studies have approached the 
numbers collected in this study. 
 
The PROMs investigated cover the four major joints, for which the majority of literature exists (hip, knee, 
shoulder & hand/wrist). The collected data has established a database of PROM population reference 
values for individuals who identify themselves as asymptomatic for the body parts under investigation. It 
is intended that these pooled values can be used as asymptomatic control cohorts for future studies 
investigating pathological cohorts.  
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CHAPTER 1 - BACKGROUND & LITERATURE REVIEW 
In an effort to improve patient outcomes, the research conducted in preparation for this thesis has been 
performed with the consideration below in mind.  
 
For clinical publications, most high-impact journals require outcome data with a minimum of 2 
years follow-up; and a control group for comparison. 
 
This thesis is primarily aimed at addressing the second part of this requirement, that being the 
establishment of a control group for comparison. 
 
The efficacy of orthopaedic surgical outcomes can sometimes be difficult to quantify and evaluate. 
There is often a spectrum of clinical and surgical results, with individual patients having different 
thresholds for their interpretation of successful or unsuccessful surgery. Objective outcome 
measurements such as joint range of motion, hospitalisation cost (1), hospital stay (2), metres walked, 
and/or complication(s), which can be easily recorded and tabulated, have been used to qualify the 
degree of surgical improvement or failure.  
 
Other subjective patient reports of pain and function have also been used to describe a patient’s 
perception of recovery and/or improvement (3). However, these reports often lack homogenous values, 
thus making comparisons between individuals or different study cohorts difficult.  
 
In an effort to quantify subjective and objective pre-operative and post-operative patient assessments, 
patient-reported outcomes (PROs), also referred to as Patient-reported outcomes measures (PROMs), 
were introduced in the 1970s(4). These scoring systems offered the opportunity to increase the 
comparability of orthopaedic surgical outcome assessments (5-8). This might enable surgeons to more 
confidently measure the severity of a patient’s symptoms and level of function, both in real time and 
longitudinally. Standardised measures have also evolved to include the assessment of a patient’s 
suitability for surgery, expected outcome and post-surgical recovery (4, 9-23).  
 
Since PROMs inception in the 1970s, their use has increased in parallel with the advent of evidence-
based medicinal practice(4). PROMs have evolved to include the assessment of patients’ suitability for 
surgery; the expected outcome and efficacy of surgical outcomes; and the monitoring of patients’ 
functional change over time (4-23). They are also valuable research tools that are being used with 
increasing frequency. In the clinical setting, PROMs have been used to guide surgical decision-making 
and enhance communication and understanding during doctor- the best reported PROM patient 
consultations (3, 5-7, 14, 24, 25). 
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A wide variety of PROMs have been described, investigated and validated (4-23, 26-39). Each assessment 
tool has its relative strengths and benefits, as well as its weaknesses. No single assessment tool has 
demonstrated consistent superiority over another(6-8). In general, the choice of which one to use comes 
down to patient population, the pathology being investigated, investigator preference and resource 
management (33, 35, 37-39). Some PROMs combine subjective patient-derived inputs with objective, 
clinician-derived inputs to establish a single score (19, 21, 23). Other assessment tools include subjective 
patient-derived reports only (10, 12, 14, 16-18, 23, 30, 33, 37). 
 
Advances in joint arthroplasty have seen an increase in the survivability of implants and a decrease in 
cumulative revision rates over the past 30 years(40). The long-term results of joint arthroplasty require 
longitudinal patient and implant assessments. Accurate interpretation of these longitudinal studies 
requires an examination of patient, surgical and implant factors that may change over time(40). PROMs 
are often used to augment the data collected by registries, thus adding important clinical data to 
supplement the revision data collected by arthroplasty registries (41-46). 
 
PROMs are now commonly used in the evaluation of hip(13, 23), knee (10, 18) and shoulder (12, 14, 15, 47-50) 
arthroplasty patient cohorts. As these cohorts often include a higher proportion of elderly participants, 
an accurate interpretation of clinical scoring data relies on an understanding that variation may exist in 
age, ethnicity, nationality and gender (40, 51). 
 
When considering PROM reports for pre-operative and post-operative clinical measures, these are best 
interpreted in comparison to asymptomatic, healthy, pathology-free, age- and gender-matched 
individuals(52). Indeed, a perfect PROM score may not reflect a realistic post-operative goal. Several 
studies have confirmed that in an asymptomatic population, the best reported PROM scores were not 
equivalent to a perfect score on the outcome scale used (48, 53, 54). In fact, an accurate interpretation of a 
patient’s PROM score requires a comparison with an age and gender-matched group of individuals who 
have not had recent surgery or joint arthroplasty (48, 54-56).  
 
Minimal research has been done to compare “normal” PROM values from different countries (57, 58). 
Recent technological advances have enabled electronic data-collection. This presents the opportunity to 
collect uniform data, quickly, efficiently and accurately across continents (58, 59). The collation of these 
data (with adherence to local government privacy requirements) enables the opportunity to establish a 
robust data collection system for future use when assessing pathological patient cohorts (60).  
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Variation in clinical PROM scoring is known to exist in different countries (25, 57). This can make research 
outcomes derived in one geographical or cultural region difficult to generalize to regions of different 
ethnicity and socioeconomic diversity. 
 
The establishment of a de-identified, asymptomatic “normal” control group within an electronic database 
would aid in improving the quality of future studies(61). An international database has the capacity to 
include de-identified data from different regions remotely. These data have the potential to make future 
multi-centre, international clinical studies more robust and capable of rapidly advancing our 
understanding of clinical outcomes. Overall, this has the potential to significantly improve the ability to 
collect reliable, validated data and enhance our practice of evidence-based medicine.  
 
The studies presented in this thesis represent the collection of independent asymptomatic participant 
cohorts for the hip, knee, shoulder and wrist, using commonly used PROM scores for each joint under 
investigation. The PROMs chosen represent internationally recognised, validated and commonly used 
clinical PROM scoring systems (10, 12-15, 18, 23, 47-50). The rationale of each selected hip (13, 23), knee (10, 18), 
shoulder (12, 14, 15, 47-50) and wrist/hand PROM (11, 12), is discussed in the publications presented in this 
thesis. Ultimately, it is envisaged that the collection of independent, international asymptomatic PROM 
cohorts will aid in the establishment of control groups for comparison, for the evaluation of future 
longitudinal pathological patient cohorts. 
 
The main aims of this thesis are: 
 
1. To assess whether a variety of the most commonly used hip, knee, shoulder and wrist PROM 
scores are equivalent in asymptomatic, healthy, pathology-free individuals of different age, 
gender and ethnicity across two remote continents.  
 
2. To establish normal population PROM values, using an electronic data collection system for 
future comparisons with pathological patient cohorts.  
The hypothesis is that there is no difference in PROM clinical score values in an asymptomatic 
population when comparing age, gender, handedness (where applicable), history of pathology, ethnicity 
and nationality. If no difference is found to exist, then any PROM could be interpreted at face value, with 
a score of 100% being assumed as the goal for all post-operative patients, irrespective of these 
variables.  
 
Each Chapter presented in this thesis represents novel research undertaken during candidature and is 
divided by the separate joint PROMs under investigation. Chapters 2 though to 5, represent the 
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research undertaken in reference to the hip, knee, shoulder and wrist/hand cohorts, respectively. Each 
cohort represent separate datasets collected during candidature, which are collated within the same 
electronic database and are de-identified. It is anticipated that these de-identified electronic datasets will 







CHAPTER 2 - NORMAL POPULATION REFERENCE VALUES FOR THE OXFORD & HARRIS HIP 
SCORES – ELECTONIC DATA COLLECTION AND ITS IMPLICATIONS 
As published in Hip International. 2017; 27 (4): 389-396. 
Introduction 
Hip Patient Recorded Outcome Measures (PROMs) are now commonly used to evaluate the efficacy of 
hip arthroplasty patients both before and following surgery. The Harris Hip Score (HHS) (23) and Oxford 
Hip Score (OHS) (13) are the most widely used. Both measures have been shown to have acceptable 
reliability and construct validity. Accurate interpretation of long-term studies requires an understanding 
of not only the surgical and implant factors, but also patient factors prior to surgery and as they change 
over time.  
Aims 
The aim of this study was to assess whether the HHS and OHS were comparable in normal, healthy, 
pathology-free individuals of different ages, gender, ethnicity and nationality. The purpose of this study 
was to establish normal population values for the HHS and OHS, using an electronic data collection 
system. The hypothesis was that there is no difference in the HHS and OHS values for the 
asymptomatic “normal” population when comparing groups that differ in age, gender, ethnicity and 
nationality. 
Main Findings 
This study represents the largest database of asymptomatic “normal” HHS and OHS PROM values 
reported in the literature (n=627). No other study has compared normal scores in international cohorts 
or collected them remotely and electronically via the same research database. Other researchers have 
reported asymptomatic values for other musculoskeletal assessment tools, but few have approached 
the numbers collected in this study; with most collecting less than 150 participants or the participants 
were limited to young, active individuals. 
 
There was an association between the OHS and age and also the HHS and age; demonstrating that as 
age increased, asymptomatic “normal” hip scores decreased. In comparing countries, the Australian 
asymptomatic group reported a statistically significant higher OHS score compared to Canadians. 
Overall, this study suggests that asymptomatic “normal” hip PROM values are comparable for 
individuals under the age of 80 years and are highly variable in individuals over the age of 80 years, 
making comparisons in this older age group less reliable. This finding suggests that there are likely 
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many other determinants of health and function that may influence the subjective hip PROM score 
reported by asymptomatic individuals and possibly the accuracy of asymptomatic “normal” values in this 
age group.  
 
This study found that objective assessments contributed less than a 1/100 point difference in 12 % of 
participants and less than a 4/100 points difference in 0.5% of the study population. This finding 
suggests that resource management and cost justification should be considered when choosing a hip 
PROM tool for future studies, as its inclusion affected less than 13% of the study population in this 
asymptomatic “normal” cohort. A subjective-only hip PROM assessment tool has several advantages, 
including remote administration, thereby negating the need be reviewed by a clinician and saving 
resources. Using a subjective-only hip PROM would likely increase the cost-effectiveness of following 
surgical outcomes, while also minimising valuable resources and clinician time. 
Future Directions 
This study has established an electronic, “normal” control group for studies using the HHS and OHS 
PROMs. Studies which include such an electronic control group should consider differences in gender, 
age, ethnicity and nationality when using hip PROMs to assess patient outcomes. An accurate 
interpretation of the HHS and OHS score in a patient with hip pathology requires a comparison with an 
age- and gender-matched groups of individuals who have not had hip arthroplasty surgery. 
 
This study found that when using the OHS, the control group should be sourced from the same country 
of origin. On the other hand, when using the HHS, the control group can be sourced from a pre-
established control group within the database, without necessarily being sourced from the same country 
of origin. This study indicates that using a hip PROM, which does not include an objective component, 
can be considered a reliable and valid measure of patient outcome. Further research is required to 
determine if this principle is applicable to a pathological cohort. The use of a subjective-only hip PROM 
is particularly relevant when cost-justification and resource management are important.  
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Introduction 
Knee Patient Recorded Outcome Measures (PROMs) are now commonly used to evaluate the efficacy 
of anterior cruciate ligament reconstruction and knee arthroplasty surgery on a longitudinal basis. The 
Knee Society Score (KSS)(18), Oxford Knee Score (OKS) (10) and Knee Injury and Osteoarthritis 
Outcome Score (KOOS) (29), are the most widely used. All three measures have been shown to have 
acceptable reliability and construct validity (27, 30, 31, 62). Accurate interpretation of long term studies 
requires an understanding of not only the surgical and implant factors, but also patient factors, both 
before surgery and as they change over time.  
Aims 
The aim of this study was to assess whether the KSS, OKS and KOOS were comparable in normal, 
healthy, pathology-free individuals of different age, gender, ethnicity and nationality. The purpose of this 
study was to establish normal population values for the KSS, OKS and KOOS using an electronic data 
collection system. The hypothesis was that there is no difference in the KSS, OKS and KOOS scores in 
the asymptomatic “normal” population in regard to age, gender, ethnicity and different nationality. 
Main Findings 
This study represents the largest database of asymptomatic “normal” KSS, OKS and KOOS PROM 
values reported in the literature (n=614). No other study has compared normal scores in international 
cohorts or collected them remotely and electronically via the same research database. Other 
researchers have reported asymptomatic values for some of the PROMs examined in this study, but few 
have approached the numbers collected in this study (63, 64); or the participants were limited to young, 
active individuals (65, 66). 
 
There was an inverse relationship between the KSS and age, OKS and age; and KOOS and age. The 
specific finding was that as age increased, reported normal knee scores decreased. This study also 
demonstrated comparable PROM scores between national cohorts and between genders. A high 
percentage of participants (27%) reported a history of an inactive knee problem, which was associated 
with 5% lower reported normal knee scores when compared to those who had no such history. 
Participants who had experienced a history of an active hip, ankle or foot problem reported 10% lower 
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normal knee scores compared to those who had no such history. These findings suggest that there may 
well be an overlap in the functional questions contained in the assessment tools. This suggests that 
these three functional tools (KSS, OKS and KOOS) may not represent knee-specific PROMs.  
Consequently, these three measures may fail to discriminate between a primarily knee disability and 
other sources of lower limb incapacity. 
Future directions 
This study has established an electronic, “normal” control group for studies using the KSS, OKS and 
KOOS PROMs. When using these PROMs the control group can be drawn from a pre-established 
control group within an existing database, without necessarily being sourced from the same country of 
origin. Care should be taken when using the KSS, OKS and KOOS PROMs in patients with multiple, 
concurrent lower limb pathology, or in patients with a history of an inactive knee problem, as these 
factors may well have an impact the PROM values reported. 
 
Studies using an electronic control group should consider differences in gender, age, ethnicity and 
nationality when using knee PROMs to assess patient outcomes. An accurate interpretation of the KSS, 
OKS and KOOS score in patients with knee pathology requires a comparison with an age- and gender-
matched groups of individuals who have not had recent knee surgery or knee arthroplasty surgery. 
Consideration should be given to the influence of other lower limb pathology and contralateral disease 
on the three PROMs used in this study when assessing a pathological cohort. 
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Abstract
Objectives The aim was to assess whether the Knee Society Score, Oxford Knee Score (OKS) and Knee Injury and Osteoar-
thritis Outcome Score (KOOS) were comparable in asymptomatic, healthy, individuals of different age, gender and ethnicity, 
across two remote continents. The purpose of this study was to establish normal population values for these scores using 
an electronic data collection system.
Hypothesis There is no difference in clinical knee scores in an asymptomatic population when comparing age, gender and 
ethnicity, across two remote continents.
Methods 312 Australian and 314 Canadian citizens, aged 18–94 years, with no active knee pain, injury or pathology in the 
ipsilateral knee corresponding to their dominant arm, were evaluated. A knee examination was performed and participants 
completed an electronically administered questionnaire covering the subjective components of the knee scores. The cohorts 
were age- and gender-matched. Chi-square tests, Fisher’s exact test and Poisson regression models were used where appro-
priate, to investigate the association between knee scores, age, gender, ethnicity and nationality.
Results There was a significant inverse relationship between age and all assessment tools. OKS recorded a significant 
difference between gender with females scoring on average 1% lower score. There was no significant difference between 
international cohorts when comparing all assessment tools.
Conclusions An electronic, multi-centre data collection system can be effectively utilized to assess remote international 
cohorts. Differences in gender, age, ethnicity and nationality should be taken into consideration when using knee scores 
to compare to pathological patient scores. This study has established an electronic, normal control group for future studies 
using the Knee society, Oxford, and KOOS knee scores.
Level of evidence Diagnostic Level II.
Keywords Assessment · Outcome · Score · Knee · Arthroplasty · Validation · Oxford · Electronic · Automated · 
Smartphone · iPhone · Laptop · Joint · Replacement
Introduction
Patient-reported outcomes measures (PROMs) can be used 
to assess the efficacy of surgical outcomes, to monitor a 
patient’s functional change over time, or as a research tool. 
More recently, knee PROMs have been used to guide surgi-
cal decision-making and enhance communication and under-
standing during doctor–patient consultations [1, 2].
PROM data has traditionally been collected in the clinic 
setting using a paper-based method. Newer, computer-based, 
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electronic PROM data collection systems allow for quicker 
data collection; automated data input and processing; and 
minimal clinician input [3].
Various knee PROMs have been described and validated 
[4–11]. Each assessment tool has its relative strengths and 
benefits, as well as its weaknesses. No single assessment 
tool has reported consistent superiority over another and the 
choice of which one to use normally comes down to patient 
population, the pathology being investigated, investigator 
preference and resource management.
The long-term results of common knee surgeries such as 
anterior cruciate ligament (ACL) reconstruction and total 
knee arthroplasty (TKA); require longitudinal patient and 
implant assessments. Accurate interpretation of these long-
term studies requires an understanding of the patient, surgi-
cal and implant factors that may change over time.
When considering using knee PROMs for pre-operative 
and post-operative clinical scoring, these are best interpreted 
when compared to asymptomatic, healthy, pathology-free, 
age- and gender-matched individuals. An accurate interpre-
tation of clinical scoring data relies on an understanding that 
variation may exist in ethnicity, nationality, gender and age. 
A perfect knee score may not reflect a realistic post-opera-
tive goal, as an accurate interpretation of a patient’s score 
requires a comparison with an age- and gender-matched 
group of individuals who have not had recent surgery or a 
TKA.
The aim of this study was to assess whether the Knee 
Society Score (KSS), the Oxford Knee Score (OKS) and the 
Knee Injury and Osteoarthritis Outcome Score (KOOS), are 
equivalent in asymptomatic, healthy, pathology-free indi-
viduals of different age, gender and ethnicity, across two 
remote continents. The purpose of this study was to establish 
normal population values for the KSS, OKS and KOOS, 
using an electronic data collection system.
Our hypothesis was that there is no difference in knee 
clinical score values in an asymptomatic population when 
comparing age, gender, ethnicity and nationality.
Methods
Independent Ethics Board approval was granted from each 
Institution involved in the study. A power calculation deter-
mined the numbers required to reach statistical significance. 
From November 2014 to December 2015, healthy volunteers 
were recruited from a variety of sources. Participants were 
approached at Drivers Licensing Offices; public libraries; 
the Outpatients of both Public and Private Medical Facili-
ties; and at various community centers (sporting, childcare, 
recreation and senior’s activity facilities). There were no 
study advertisements and participants were not paid for their 
involvement.
Participants were included if they were 18 years of age 
or older; fluent in English; Australian or Canadian citizens; 
and reported both knees as “normal”. For the purpose of 
the study where appropriate, participants were directed to 
answer the questions with reference to their ipsilateral knee 
corresponding to their dominant arm (ipsilateral knee). 
Exclusion criteria included participants with: a history of 
any inflammatory arthritis; significant lumbar spine prob-
lems that interfered with their mobility or function; or cog-
nitive impairment or language problems. Participants were 
also excluded if they had active (i.e., painful or sympto-
matic) ipsilateral knee pathology; a history of ipsilateral 
knee joint arthroplasty; or ipsilateral knee surgery within 
the past 3 years. A history of inactive (i.e., no longer symp-
tomatic) ipsilateral knee pathology, including previous 
surgery, was recorded, but was not considered part of the 
exclusion criteria. A history of active hip, ankle and/or foot 
pathology was recorded; as well as contralateral knee pathol-
ogy (but these were also not considered part of the exclusion 
criteria). Eligible participants gave informed consent.
The study included 626 healthy volunteers, free of knee 
pathology. The Australian cohort included 162 (51.9%) pri-
vately insured participants with the remaining 150 (48.1%) 
being publically insured by the federal government. The 
Canadian federal government insures 100% of the Canadian 
population, representing an entirely publically funded health 
care system.
The Australian cohort included 155 males and 157 
females. The average age was 53 years (range 18–93); 34 
(10.9%) left and 278 (89.1%) right ipsilateral knees were 
included.
The Canadian cohort included 159 males and 155 
females. The average age was 53 years (range: 18–91); 32 
(10.2%) left and 282 (89.8%) right ipsilateral knees were 
included.
An electronic, web-based outcomes based electronic 
research database (OBERD, Universal Research Solutions, 
Columbia, Missouri, USA) was used to administer the KSS, 
OKS and the KOOS questionnaires. The details of these 
instruments are described in the following section.
Participants self-administered using an electronic mobile 
device (Smartphone, iPad or other electronic tablet device), 
or a laptop computer. If a participant had difficulty in com-
pleting the questionnaire, due to visual impairment, impaired 
dexterity, or computer unfamiliarity, a researcher completed 
it for them by verbally asking the questions and recording 
their responses. Where appropriate, participants were asked 
to complete the questions with reference to their ipsilateral 
knee corresponding to their dominant arm.
Participants were then assessed clinically and measure-
ments of their pain-free, active range of motion (ROM), knee 
angulation and stability were recorded. ROM was assessed 
in the seated or supine position, using the axis of the femoral 
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and tibial bones, and the greater trochanter, distal femoral 
condyles and lateral malleolus as reference points. A sin-
gle, highly experienced trained observer performed all of 
the assessments in North America. In Australia, two trained 
observers with less experience performed all of the assess-
ments. Inter-variability correlation was performed.
The results were electronically transferred to the research 
database using OBERD. The combined subjective and objec-
tive assessments were combined electronically to determine 
the participant’s KSS. This method enabled minimal data 
handling by the recruiters, ensuring that the investigators 
were partially blinded to the participants’ results.
Primary outcome measures
Oxford Knee Score (OKS)
The OKS is a 12-item knee assessment tool. It is a purely 
subjective patient-report of pain, function and disability 
[2]. There are no objective, clinician-derived inputs. Each 
of the 12-items are scored from 0 to 4, with 4 representing 
best outcome/least symptoms. Scores from each question 
are added so the overall score ranges from 0 to 48, with 48 
being the best score possible. The OSS score has been found 
to be simple and reliable, and to have excellent reliability 
and construct validity [4, 11].
Knee Society Score (KSS)
The KSS is a 7-item knee assessment tool. It is comprised 
primarily of objective data, with 6/7 of the inputs involv-
ing clinical assessments and the last input being a subjec-
tive, patient-report of pain. The clinician input includes an 
objective assessment of knee alignment, stability and ROM 
[5]. The responses are made on a visual analog scale, com-
bined, and then scaled to a 100-point sum, where 100 is the 
best score possible [5]. The KSS has been shown to have 
acceptable reliability and construct validity [6, 10]. Scores 
are rated excellent (80–100); good (70–79); fair (60–69); or 
poor (less than 60).
Knee Injury and Osteoarthritis Outcome Score (KOOS)
The KOOS is a 42-item knee assessment tool. It is a purely 
subjective patient-report of knee symptoms, function and 
quality of life [8]. There are no objective, clinician-derived 
inputs. The responses are made on a visual analog scale, 
under the following sections: symptoms (KOOS-S: 5 for 
symptoms and 2 for stiffness); pain (KOOS-P: 9 items); 
function [17 items for daily activities (KOOS-DL) and 5 
items for sport and recreational activities (KOOS-SR)]; and 
quality of life (KOOS-QOL: 4 items). The responses are 
combined, and then scaled to a 100-point sum, where 100 
is the best score possible [8]. The KOOS has been shown to 
have acceptable reliability and construct validity [9].
Statistical analysis
Prior to analysis, the database was checked for missing data. 
Data analyses were performed using the IBM SPSS V.20 
statistical package for Windows and SAS 9.3 (SAS Institute 
Inc., Cary, NC, USA).
A power calculation was performed by a statistician that 
determined the minimum sample size required to reach sta-
tistical significance (n = 574). Associations between nation-
ality and age, gender, handedness and ethnicity, were inves-
tigated using chi-square tests and Fisher’s exact test where 
appropriate. Due to the relatively low numbers recorded in 
some ethnic groups, no statistically significant comparisons 
could be made between the individual ethnic groups.
Poisson regression models were then used to investigate 
the association between knee scores, nationality, gender and 
age. Linear regression was not performed because, although 
the outcome variables (knee scores) were continuous, resid-
uals from linear regression models were very left-skewed 
and could not be corrected using logarithmic transformation. 
The knee scores were therefore considered to be counts. Dis-
persion values for the Poisson regressions performed ranged 
from 0.0124 to 3.1994. Two-sided confidence intervals were 
set at 95% for two-way mixed effects model and absolute 
agreement. Interaction models were performed between 
nationality and age category; or gender versus the knee score 
outcomes. If the interaction was not significant, then main 
effects models were presented.
Results
There were no incomplete questionnaires. The cohort demo-
graphics are presented in Tables 1 and 2. There was no dif-
ference between the international cohorts when compar-
ing age (p = 0.7826); gender (p = 0.8107); or handedness 
(p = 0.7736) (Table 1).
Overall, 27.2% Australians and 26.7% Canadians 
reported a history of an inactive knee problem, with 9.3% 
Australian and 9.2% Canadian of participants report-
ing having had non-arthroplasty knee surgery more than 
3 years ago (Table 2). This difference was not statistically 
significant (p = 0.9282). There was a statistically signifi-
cant association between all seven knee scores and partici-
pants with a history of an inactive knee problem (all seven 
models p < 0.001). For example, age- and gender-matched 
participants who reported a history of an inactive knee 
problem had a mean KSS score 4.8% lower than those 
who had no such history (IRR = 1.048; 95% CI: 1.029, 
1.067). Similar statements could be made for the KOOS 
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Table 1  A comparison 
of ethnicity of the two 
international cohorts
Due to the relatively low numbers recorded in some ethnic groups, no statistically significant comparisons 
could be made between the individual ethnic groups
Ethnicity Australia (n = 312) Canada (n = 314) Total
Asian Indian 8 (2.5%) 13 (4.1%) 21 (3.4%)
Black or African American 3 (1%) 3 (1%) 6 (1%)
Caucasian 290 (93%) 233 (74%) 522 (83.4%)
Chinese 6 (1.9%) 29 (9.2%) 35 (5.6%)
Filipino 0 9 (2.9%) 9 (1.5%)
Indigenous 1 (0.3%) 2 (0.6%) 3 (0.5%)
Middle Eastern 2 (0.6%) 14 (4.5%) 16 (2.6%)
Other Asian 2 (0.6%) 8 (2.6%) 10 (1.6%)
Central/South American 0 3 (1%) 3 (0.5%)
312 314 626 (100%)
Table 2  Comparison of 
Australian and Canadian 
cohorts by demographics
Australian cohort (n = 312) Canadian cohort (n = 314) Total Comparing Australian 
and Canadian cohorts
Male
 155 (49.7%) 159 (50.6%) 314 (50.2%) p = 0.8107
Female
 157 (50.3%) 155 (49.4%) 312 (49.8%)
Left
 34 (10.9%) 32 (10.2%) 66 (10.5%) p = 0.7736
Right
 278 (89.1%) 282 (89.1%) 560 (89.5%)
Age < 30
 30 (9.6%) 30 (9.6%) 60 (9.6%) p = 0.9992
Age 30–39
 35 (11.2%) 33 (10.5%) 68 (10.9%)
Age 40–49
 53 (17.0%) 50 (15.9%) 103 (16.5%)
Age 50–59
 73 (23.4%) 76 (24.2%) 149 (23.8%)
Age 60–69
 70 (22.4%) 73 (23.3%) 143 (22.8%)
Age 70–79
 35 (11.2%) 37 (11.8%) 72 (11.5%)
Age 80+
 16 (5.1%) 15 (4.8%) 31 (5.0%)
Average age




 150 (48.1%) 314 (100%)
Participant reported a history of an inactive (previous) knee problem
 85 (27.2%) 84 (26.7%) 169 (27%) p = 0.9282
See comment
Participant reported a history of an active hip, ankle or foot problem
 22 (7%) 39 (12.4%) 61 (9.7%) p = 0.0253
Participant reported having had non-arthroplasty knee surgery more than 3 years ago
 29 (9.3%) 29 (9.2%) 58 (9.3%) p = 0.9283
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and OKS. There is a statistically significant association 
between report of history of inactive knee problem and 
age (p = 0.0055). This is an expected result, that as age 
increases the incidence of having had a knee problem 
increases.
A higher proportion of Canadian participants reported 
an active hip, ankle or foot problem (12.4 versus 7.0% 
of Australian participants; p = 0.0253; OR = 1.87, 95% 
CI:1.08, 3.23; Table 2). There was an association between 
all seven knee scores and participants with an active hip, 
ankle or foot problem (all seven models p < 0.001). For 
example, age- and gender-matched participants with an 
active hip, ankle or foot problem reported a mean OKS 
value 10.8% lower than those who had no such history 
(IRR = 1.108, 95% CI:1.064, 1.154). Similar statements 
could be made for the KOOS and OKS. Association 
between report of having an active hip, ankle of foot prob-
lem and age showed a trend, but did not reach statistical 
significance (p = 0.0848).
An inverse relationship was observed between age and 
PROM scores in all categories (Figs. 1, 2). PROM values 
are presented in Tables 3, 4, 5,6, and 7.
Oxford Knee Score
There was a statistically significant association between 
the OKS and age (Fig.  1), adjusting for nationality 
(p < 0.0001). For every 1-year increase in age, the mean 
OKS value decreased by 0.17% (Tables 3, 4; IRR = 0.9983; 
95% CI: 0.9976, 0.9990).
There was no association between OKS and gender 
(p = 0.7697); handedness (p = 0.6086); or nationality, 
adjusting for gender (p = 0.6837) and adjusting for age 
(p = 0.7406).
Knee Society Score: clinician objective component
49 participants (7.8%) did not score the potential maximum 
50/100 points for the clinician-assessed objective compo-
nent. Of these participants, the average score was 1.2/50 
(range 0.0–3.0). Forty one (6.6%) recorded a total ROM 
70°–120° (mean total ROM = 110.0, range 75.2, 120.0; rep-
resenting a loss of 1 to 10 points); 4 (0.6%) recorded an 
extension lag (allocated as a minus score of between − 5 and 
− 10); 25 (4.0%) reported a flexion contracture (allocated as 
a minus score of − 2 to − 15); 12 (1.9%) recorded an antero-
posterior laxity greater than 5 mm (allocated as a minus 
score of − 2 to − 15); and 22 (3.5%) recorded medio-lateral 
laxity greater than 5 mm (representing a loss of 5–15 points).
Knee Society Score: total
There was a statistically significant association between 
OKS and KSS (p < 0.0001). For every one unit increase in 
OKS, the KSS value increased by 1.6% (IRR = 1.016, 95% 
CI: 1.014, 1.019).
There was a statistically significant association 
between the KSS and age (Fig. 2), adjusting for national-
ity (p < 0.0001). For every 1-year increase in age, the mean 
KSS value decreased by 0.15% (Tables 5, 6; IRR = 0.9985, 
95% CI: 0.9980, 0.9990).
There was a statistically significant association between 
KSS and gender, adjusting for nationality (p = 0.0124). 
Specifically, female participants reported a mean KSS 1.0% 
lower than age-matched males (IRR = 0.9799; 95% CI: 
0.9644, 0.9956).
There was no association between KSS and handedness 
(p = 0.2837); or KSS and nationality, adjusting for gender 
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Fig. 2  Scatter plot of Knee Society Score versus age by country
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Knee Injury and Osteoarthritis Outcome Score: total
There was no significant association between each KOOS 
subcategory and gender or handedness (Table 7).
There was a statistically significant association between 
each KOOS subcategory and age. For every 1-year 
increase in patient age, KOOS-DL decreased by 0.14% 
(IRR = 0.9986; 95% CI: 0.9981, 0.9991); KOOS-P decreased 
by 0.12% (IRR = 0.9988; 95% CI: 0.9983, 0.9993); KOOS-
QOL decreased by 0.29% (IRR = 0.9971; 95% CI: 0.9966, 
0.9976); KOOS-SR decreased by 0.45% (IRR = 0.9955; 
95% CI: 0.9950, 0.9960); and KOOS-S decreased by 0.10% 
(IRR = 0.9990; 95% CI: 0.9985, 0.9995).
There was no association between KOOS subcategories 
and nationality, adjusting for gender and adjusting for age 
(Table 7).
Discussion
In this study, data were collected electronically from two 
asymptomatic, distinct, remote, Westernized populations of 
different countries, that were representative of their local 
populations [12, 13]. The ratio of participants of European 
descent (Caucasians by default) represented in the Austral-
ian cohort is consistent with that reported by the Australian 
Bureau of Statistics [12]. The higher proportions of Chinese, 
Middle Eastern and Asian Indians represented in the Cana-
dian cohort, is consistent with that reported by the Govern-
ment of Canada statistics [13].
To our knowledge, this study represents one of the larg-
est databases of combined OKS, KSS and KOOS asympto-
matic, normal values reported in the literature. Other studies 
have recorded normal values for knee outcome scores but 
few have approached the numbers collected in this study.
Paradowski collected normal reference values for KOOS 
on randomly chosen subjects in Sweden. Their study 
reported a response rate of 539/840, leading to response 
bias (as individuals with chronic pain issues are more likely 
to respond) [14]. Other studies have reported that subjects 
with a previous history of knee problems have a tendency to 
respond to medical surveys more readily than those without 
[15]. These studies were limited by comparing only a single 
PROM assessment tool; and limited to a single population 
cohort. These studies also used traditional paper assess-
ments, requiring further data input for analysis.
The authors committed resources to collecting objective 
clinical data to complete the KSS. This study of asymp-
tomatic individuals, reported that KSS, KOOS and OKS 
PROMs were comparable. This important finding led us to 
re-evaluate the importance of collecting objective data for 
calculating the KSS. As resource management and cost jus-
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consideration should be given to a knee PROM tool that 
is equivalent to the KSS, but does not require an objective 
assessment component. A subjective-only knee PROM 
assessment tool has several advantages. One of these 
advantages includes the ability to administer questionnaires 
remotely, negating the need for patients to be reviewed by a 
clinician, thereby increasing their cost-effectiveness.
There was no association between KSS, KOOS and OKS 
and nationality, adjusted for age and gender. As the KSS, 
KOOS and OKS PROMs were comparable, this also sug-
gests that future studies comparing pathological cohorts, 
can be performed with comparison against a pooled control 
group, without necessarily needing to be sourced from the 
same country of origin as the proposed study. Further stud-
ies need to be completed to determine whether this principle 
applies to other countries that use electronic data collection, 
particularly the United States and Great Britain.
An electronically administered PROM enables more 
streamlined data collection, collating, processing and anal-
yses. It is accessible to remote clinical researchers; allows 
simultaneous data entry and data analyses; has the potential 
to link to an electronic medical record; and enables patients 
the convenience of completing questionnaires remotely 
in their own time, or automating participant reminders or 
response time points. However, electronically administered 
questionnaires require respondents to be computer savvy; an 
assumption that may not be correct for all members of the 
public [16]. Patients with severe wrist and hand pathology 
may also be less willing to complete online questionnaires 
using computers or tablets.
Table 4  Confidence intervals and comparison p values for Oxford knee scores
Interaction Group Comparison Incidence 
rate ratio
Lower 95% CL Upper 95% CL Comparison p value Interaction p value
Country < 30 Australia versus 
Canada
1.0086 0.9373 1.0853 0.8198 0.9704
30–39 Australia versus 
Canada
0.9851 0.9191 1.0558 0.6710
40–49 Australia versus 
Canada
0.9895 0.9352 1.0470 0.7136
50–59 Australia versus 
Canada
1.0061 0.9595 1.0549 0.8015
60–69 Australia versus 
Canada
1.0022 0.9540 1.0528 0.9298
70–79 Australia versus 
Canada
1.0289 0.9598 1.1030 0.4219
80+ Australia versus 
Canada
1.0330 0.9286 1.1492 0.5505
Australia 80+ versus < 30 0.9284 0.8486 1.0157 0.1050
Canada 80+ versus < 30 0.9064 0.8259 0.9947 0.0384
Hx of knee problem < 30 Yes versus No 0.9739 0.8394 1.1299 0.7272 0.2044
30–39 Yes versus No 0.9407 0.8640 1.0243 0.1593
40–49 Yes versus No 0.9757 0.9132 1.0426 0.4675
50–59 Yes versus No 0.9362 0.8877 0.9873 0.0150
60–69 Yes versus No 0.8985 0.8525 0.9470 < 0.0001
70–79 Yes versus No 0.9149 0.8496 0.9853 0.0187
80+ Yes versus No 0.8065 0.7042 0.9235 0.0019
Yes 80+ versus < 30 0.7935 0.6572 0.9580 0.0161
No 80+ versus < 30 0.9582 0.8932 1.0279 0.2333
Hip or ankle problem < 30 Yes versus No 0.9219 0.6845 1.2417 0.5927 0.6597
30–39 Yes versus No 0.9778 0.8244 1.1596 0.7961
40–49 Yes versus No 0.9587 0.8737 1.0521 0.3738
50–59 Yes versus No 0.8627 0.7890 0.9433 0.0012
60–69 Yes versus No 0.8878 0.8180 0.9635 0.0044
70–79 Yes versus No 0.9377 0.8550 1.0284 0.1719
80+ Yes versus No 0.8854 0.7498 1.0455 0.1512
Yes 80+ versus < 30 0.8936 0.6397 1.2483 0.5095
No 80+ versus < 30 0.9305 0.8697 0.9955 0.0366
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It is an important goal to differentiate normal, age-
related changes in function, from those changes associated 
with pathological conditions. An inverse relationship was 
observed between age and PROM score, indicating that as 
age increases, the degree of baseline asymptomatic disability 
increases. There was a further significant inverse relation-
ship within each subcategory of the KOOS, with the sports 
and recreations subcategory showing the largest decrease 
of 0.45% with each year of age. The greatest variation in 
PROM values were recorded in the ≥ 80 age group, with 
some respondents recording values of 48/48 and 100/100 
(even up to 90 years); and others recording values half that 
of a perfect score. This finding is not surprising, given the 
age-related changes that occur over time, as well as the 
accumulated medical and surgical comorbidities that can 
affect lower limb function. This study also showed a sig-
nificant association between age and reporting of inactive 
knee pathology confirming that as age increases a history or 
knee problems increases. There are likely many other deter-
minants of health and function that may influence a partici-
pant’s PROM score, and possibly the accuracy of “normal” 
values in this age group. Certainly, as patient age increases, 
perfect PROMs should not be expected following surgical 
interventions.
This study reported an association between a history 
of inactive knee pathology and all PROMs assessed. This 
seems logical and as such, should be taken into considera-
tion when choosing an asymptomatic, normal control group 
to compare against a pathological or interventional group.
Participants with a history of dominant knee pathology 
treated by non-arthroplasty/arthrodesis surgery > 3 years ago 
and no longer experiencing symptoms were included. It is 
possible that some of these participants still suffered from 
some slight impairment as a result of their previous condi-
tion/surgery; however, we only included those who no longer 
perceived their issue to be a problem.
This study reported an association between a history of an 
active hip, ankle or foot problem and all PROMs assessed. 
There is significant overlap in the functional questions 
contained in the other assessment tools which suggests 
that these functional tools may not represent knee specific 
PROMs and may fail to discriminate a primarily knee source 
of disability from other sources of lower limb incapacity. 
This should be considered when using these tools in patients 
with multiple, concurrent lower limb pathologies.
The current study has important limitations that should 
be considered when interpreting the results. As with any 
observational study, there is the potential for selection bias, 
particularly when there is no randomization. Although indi-
viduals were approached randomly in this study, no spe-
cific randomization method of participant identification 
was employed. Another potential source of interviewer bias 
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participants may have declined to be involved due to the 
technology.
Participants with a history of a prior knee injury may 
have chosen not to participate in the study, citing that their 
knee was not “normal”. Although we chose to exclude par-
ticipants with active knee pathology, we did include par-
ticipants with a history of a previous knee problem that 
“no longer bothered them”. As this is a purely subjective 
report, it is possible that some of those individuals who had 
a prior knee problem may have only minor functional inca-
pacities, and should have been included in the study. As 
no X-rays were taken to confirm whether participants had 
asymptomatic degenerative knee disease, it is possible that 
some of these individuals were included in the cohorts. It is 
assumed that a small percentage of the general population 
will have asymptomatic or incidental undiagnosed knee 
pathology; however, we attempted to exclude subjects with 
active knee pathology as much as was practical. Previous 
studies reporting the collection of “normative values” have 
not made attempts to exclude subjects with pathology to the 
same extent this study has.
The carefully chosen inclusion and exclusion criteria 
was aimed at collecting an asymptomatic population who 
identified themselves as having ‘normal’ knees. Partici-
pants initially identified themselves as having no knee 
problems. Participants were then directed to answer the 
remainder of the questionnaire in reference to their knee 
that corresponded to their dominant hand. The Authors 
acknowledge that a participant’s PROM value may be 
influenced by their contralateral knee, in a similar manner 
Table 6  Confidence intervals and comparison p values for Knee Society scores
Interaction Group Comparison Incidence 
Rate Ratio
Lower 95% CL Upper 95% CL Comparison p value Interaction p value
Country < 30 Australia versus 
Canada
1.0033 0.9538 1.0555 0.8972 0.2089
30–39 Australia versus 
Canada
0.9815 0.9357 1.0297 0.4454
40–49 Australia versus 
Canada
0.9892 0.9514 1.0285 0.5861
50–59 Australia versus 
Canada
1.0170 0.9844 1.0506 0.3098
60–69 Australia versus 
Canada
1.0075 0.9742 1.0419 0.6643
70–79 Australia versus 
Canada
1.0384 0.9899 1.0893 0.1222
80+ Australia versus 
Canada
1.0937 1.0154 1.1782 0.0182
Australia 80+ versus < 30 0.9406 0.8842 1.007 0.0526
Canada 80+ versus < 30 0.8629 0.8083 0.9211 < 0.0001
Hx of knee problem < 30 Yes versus No 1.0018 0.9051 1.1087 0.9725 < 0.0001
30–39 Yes versus No 0.9903 0.9346 1.0492 0.7406
40–49 Yes versus No 0.9966 0.9523 1.0430 0.8837
50–59 Yes versus No 0.9701 0.9356 1.0059 0.1003
60–69 Yes versus No 0.9241 0.8917 0.9576 < 0.0001
70–79 Yes versus No 0.9978 0.9489 1.0492 0.9319
80+ Yes versus No 0.7470 0.6781 0.8228 < 0.0001
Yes 80+ versus < 30 0.7143 0.6263 0.8147 < 0.0001
No 80+ versus < 30 0.9580 0.9125 1.0057 0.0832
Hip or ankle problem < 30 Yes versus No 1.0017 0.8220 1.2206 0.9866 0.0342
30–39 Yes versus No 0.8553 0.7547 0.9693 0.0143
40–49 Yes versus No 0.9888 0.9281 1.0535 0.7287
50–59 Yes versus No 0.9425 0.8884 0.9998 0.0494
60–69 Yes versus No 0.9681 0.9172 1.0217 0.2385
70–79 Yes versus No 0.8787 0.8235 0.9375 < 0.0001
80+ Yes versus No 0.8421 0.7483 0.9476 0.0043
Yes 80+ versus < 30 0.7750 0.6186 0.9709 0.0267
No 80+ versus < 30 0.9219 0.8797 0.9662 0.0007
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to a pathological patient’s PROM score being influenced 
by their unreported, contralateral knee function. The 
Authors believe this represents a variation in the patho-
logical data sets. It is assumed that the contralateral knees 
in this study would have a similar distribution of coin-
cident asymptomatic or undiagnosed pathology/normal 
contralateral knee function, as the pathological cohorts 
that it will be compared to in the future.
Concusion
Differences in age and gender should be taken into con-
sideration when using the OKS, KSS and KOOS to assess 
patient outcomes. This study demonstrated comparable 
scores between national cohorts, suggesting that future 
international studies using these assessment tools can be 
performed using a standardized control group, without 
necessarily needing to be sourced from the same country 
of origin as the proposed study. Further studies need to be 
completed to determine whether this principle applies to 
other countries that using an electronic database.
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CHAPTER 4 - AN INTERNATIONAL, MULTI-CENTRE COHORT STUDY COMPARING SIX 
SHOULDER CLINICAL SCORES IN AN ASYMPTOMATIC POPULATION 
As published in Journal of Shoulder & Elbow Surgery. 2018 Feb; 27(2): 306-314. 
Introduction 
Shoulder PROMs are commonly used to evaluate the efficacy of arthroscopic shoulder surgery, open 
rotator cuff surgery and shoulder arthroplasty surgery over a longitudinal period (25, 47, 67-71). Several 
shoulder PROMs have been described and validated (14, 16, 17, 21, 47, 53, 56). This thesis investigated six 
clinical measures including the American Shoulder and Elbow Surgeons (ASES) shoulder score (16); the 
Constant-Murley Shoulder Score (CSS) (53); the Oxford Shoulder Score (OSS) (14, 47); the University of 
California, Los Angeles (UCLA) shoulder score (21); the Shoulder Pain and Disability Index (SPADI) (17); 
and the Stanmore Percentage of Normal Shoulder Assessment (SPONSA) (56). Accurate interpretation 
of long-term studies requires an understanding of not only the surgical and implant factors, but also 
patient factors that may change over time.  
Aims 
The aim of this study was to assess whether the ASES, CSS, OSS, UCLA, SPADI, and SPONSA 
shoulder scores were comparable in normal, healthy, pathology-free individuals of different age, gender, 
ethnicity, handedness and nationality. The purpose of this study was to establish normal population 
values for the six PROM shoulder scores being investigated, using an electronic data collection system. 
The hypothesis was that there is no difference in the PROM shoulder score values in an asymptomatic 
“normal” population when comparing sub-groups of differing age, gender, ethnicity and nationality. 
Main Findings 
This study represents the largest database of asymptomatic “normal” shoulder PROM values reported 
in the literature (n=635). No other study has compared six shoulder PROMs in an asymptomatic 
“normal” cohort. This study represents the only available data on normative SPADI (17) and SPONSA (56) 
values in the literature. Other researchers have reported asymptomatic values for some of the PROMs 
examined in this study (48, 54, 55, 72), but few samples have approached the numbers collected in this 
study. Frequently, the participants were limited to young, active individuals, which was not the case in 
the present study(48). 
 
There was an association between the PROM shoulder scores being investigated and age, 
demonstrating that, as age increased, reported PROM scores were poorer. In individuals aged over 80 
years old, there was a greater variation in PROM values reported, suggesting that comparisons within 
 47 
this older age group may be less reliable. This finding suggests that there are likely many other 
determinants of health and function that may influence the subjective shoulder PROM score reported, 
and possibly the accuracy of asymptomatic “normal” values in this older age group. 
 
Women reported similar or poorer PROM scores for all PROMs assessed, but poorer scores for females 
only reached statistical significance in three out of the six PROMs being investigated (ASES, CSS, and 
SPADI). Other studies have also reported poorer scores in asymptomatic “normal” females participants 
(53, 55).There was a statistically significant difference between the international cohorts for three out of the 
six PROMs (ASES, UCLA, and SPADI). This may reflect a true difference between the population 
cohorts, or a selection or reporting bias.  
 
Fifteen percent of participants reported a history of an inactive shoulder problem. This sub-group 
reported 2% lower shoulder scores, compared to those who had no such history. This suggests that a 
history of an inactive shoulder problem should be taken into consideration when choosing an 
asymptomatic “control” group to compare against an interventional group. 
 
Interestingly, participants who reported a history of an active elbow, wrist or hand problem reported 
similar PROM scores compared to those who had no such history. This finding supports the conclusion 
that these six shoulder PROMs are specific to the shoulder and can discriminate shoulder-based 
pathology from other sources of upper-limb incapacity. To the Author’s knowledge, this finding has not 
previously been reported in the literature for these six PROMs.  
 
There was a statistically significant correlation between all shoulder PROM assessment tools, with no 
difference identified when comparing subjective-only PROMs with combined subjective-objective 
PROMs. This finding suggests there may be no advantage in using a combined subjective / objective 
assessment tool, which requires additional resources, personnel and expertise to facilitate. To the 
Author’s knowledge, this finding has not previously been reported in the literature for these six PROMs. 
Future directions 
An accurate interpretation of a shoulder PROM score from a patient with shoulder pathology requires a 
comparison with an age- and gender-matched group of individuals who have not had recent shoulder 
surgery or shoulder arthroplasty surgery. Studies using an electronic control group should consider 
differences in gender, age, ethnicity, handedness, history of pathology and nationality, when using 
shoulder PROMs to assess patient outcomes.  
 
 48 
This study has established an electronic, asymptomatic “normal” control group for studies using the 
ASES, CSS, OSS, UCLA, SPADI, and SPONSA shoulder scores. When using the ASES, UCLA, and 
SPADI PROMs, the control group should be sourced from the same country of origin as the proposed 
study. Care should be taken when assessing patients aged over 80 years old, females, or those with a 
history of an inactive shoulder problem, as these factors are likely to have an impact on the PROM 
values reported. 
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The collection of preoperative and postoperative patient-
reported outcome measures (PROMs) has traditionally been
used to assess the efficacy of surgical interventions.12 Since
their inception, PROMs have been used with increasing fre-
quency to measure the severity of a patient’s symptoms and
level of function. They can also be used as adjuncts to enhance
communication and understanding during doctor-patient
consultations.7,9
PROM data have traditionally been collected in the
clinic setting using a paper-based method. Newer computer-
based, electronic PROM data collection systems allow for
remote data collection and questionnaire administration, au-
tomated data input and processing, quicker and real-time data
collation, and minimal clinician input.13
Various shoulder PROM clinical scores have been de-
scribed and validated. Several studies have confirmed that in
an asymptomatic population, the best possible shoulder score
may not be equivalent to a perfect score on the outcome scale
used.3,4 Preoperative and postoperative clinical scores are best
interpreted when compared with normal, healthy, pathology-
free age- and sex-matched individuals.16 An accurate
interpretation of clinical scoring data relies on an understand-
ing that variation may exist with regard to sex, age, ethnicity,
and geographical location.
The aim of this study was to assess whether 6 common-
ly used shoulder PROM clinical scores were equivalent in
asymptomatic, healthy individuals of different sexes,
ages, ethnicities, and geographical locations. The study com-
pared subjective-only and combined subjective-objective
PROMs with questionnaires administered and data collect-
ed electronically, including over 600 participants. The clinical
scores under investigation included the American Shoulder
and Elbow Surgeons (ASES) shoulder score; the Constant-
Murley Shoulder Score (CSS); the Oxford Shoulder Score
(OSS); the University of California, Los Angeles (UCLA)
shoulder score; the Shoulder Pain and Disability Index
(SPADI); and the Stanmore Percentage of Normal Shoulder
Assessment (SPONSA).
Our hypothesis was that there would be no difference in
shoulder PROM clinical scores in an asymptomatic population
between sexes, age groups, ethnic groups, and geographical
locations. If no difference existed, then any shoulder PROM
could be interpreted at face value, with a score of 100% being
assumed as the goal for all postoperative patients, irrespec-
tive of sex, age, ethnicity, or geographical location.
Methods
From November 2014 to November 2015, healthy volunteers were
recruited from a variety of sources. Participants were approached
at driver’s licensing offices, public libraries, the outpatient ser-
vices of both public and private medical facilities, and various
community centers (sporting, childcare, recreation, and senior ac-
tivity facilities). There were no study advertisements, and participants
were not paid for their involvement.
Participants were included if they were aged at least 18 years;
were fluent in English; were Australian or Canadian citizens;
and had no diagnosed shoulder pathology in the dominant arm.
The exclusion criteria included participants with a history of
any inflammatory arthritis, significant neck problems, or cognitive
impairment or language problems. Participants were also ex-
cluded if they had active dominant shoulder pathology or had a
history of dominant shoulder surgery that included recent surgery
(within the past 3 years) or joint arthroplasty. A history of inactive
dominant shoulder pathology including previous surgery (>3 years
ago) was recorded but was not considered part of the exclusion
criteria. A history of ipsilateral elbow, wrist, or hand pathology
was recorded, but this was also not considered part of the exclu-
sion criteria.
Eligible participants underwent an informed consent process. The
study included 635 participants free of active shoulder pathology
(323 Australian and 312 Canadian citizens). The Australian cohort
included 163 male and 160 female participants; the average age was
53.5 years (range, 20-89 years); 31 were left hand dominant. The
Canadian cohort included 153 male and 159 female participants;
the average age was 53.8 years (range, 19-90 years); 26 were left
hand dominant.
An electronic, Web-based software system (OBERD [Out-
comes Based Electronic Research Database]; Universal Research
Solutions, Columbia, MO, USA) was used to combine several of
the shoulder PROM instruments to create 1 condensed instrument.
Condensed, electronically administered questionnaires have
been shown to have comparable results to individually adminis-
tered paper-based PROMs.13,25 All questions were stated exactly
as in the original instruments, added sequentially together. When
appropriate, both imperial and metric values were stated. The
shoulder outcome instruments assessed included the ASES
shoulder score, CSS, OSS, UCLA shoulder score, SPADI, and
SPONSA. The details of these instruments are described in the
following section.
The questionnaire was self-administered by participants with ref-
erence to their dominant shoulder, using an electronic mobile device
(smartphone or tablet computer) or a laptop computer. If partici-
pants had difficulty in completing the questionnaire because of
computer unfamiliarity, visual impairment, or impaired dexterity,
an investigator completed it for them by verbally asking the ques-
tions and recording their responses.
All participants were then assessed clinically, and measure-
ments of their range of motion (ROM) and strength were recorded.
ROM was assessed using the smartphone application DrGoniometer
(version 1.9; CDM SrL, Milan, Italy).20 Participants’ pain-free active
ROM was assessed in the seated position, using the axis of the arm
and the spinous processes of the thoracic spine as reference points.6
Subjective shoulder strength was assessed using the 6 grades (0-5)
described by the Medical Research Council.15 Objective shoulder
strength was measured using an IDO Isometer (Innovative Design




The ASES shoulder score is a 17-item patient report of pain, func-
tion, and disability, scored out of 100, which has been shown to have
acceptable reliability and construct validity.17,22
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Constant-Murley Shoulder Score
The CCS is an 8-item combined patient-clinician report of pain, func-
tion, ROM, and strength, which is scaled out of 100 points.6 It has
been found to be easy and quick to use and to allow interpreta-
tions comparable to those of other, more sophisticated scoring
systems.5,6
Oxford Shoulder Score
The OSS is a 12-item patient report of pain, function, and disabil-
ity with a maximal 48 points.9 It is simple and reliable and has been
shown to have excellent reliability and construct validity.8,10
UCLA shoulder score
The UCLA shoulder score is a 5-item combined patient-clinician
report of pain, function, ROM, strength, and patient satisfaction. It
is easy and quick to use and allows interpretations comparable to
those of other, more sophisticated scoring systems.19 This item is
usually scored out of 35 points and was modified in our study to
exclude points for postoperative patient satisfaction, giving a
maximum score of 30 points.
Shoulder Pain and Disability Index
The SPADI is a 13-item patient report of shoulder pain and dis-
ability, with 0 as the best score and 100 as the poorest; it has been
shown to have excellent reliability and construct validity.18,23
Stanmore Percentage of Normal Shoulder Assessment
The SPONSA is a single-question patient report with a score from
0 to 100 for shoulder pain, range of movement, strength, stability,
and function. It has been found to be practical and quick to admin-
ister, with excellent reliability and construct validity.21
Statistical analysis
A power calculation was performed to determine the sample size
necessary to detect a clinically significant difference in shoulder
score of 20% at a power of 80% and an α value of .05 (n = 596).
Associations between sex, age, ethnicity, and geographical loca-
tion were investigated using Poisson and log-linear regression analysis.
The primary outcome measures were not normally distributed on
linear regression; hence, this analysis was not used. The SPADI out-
comes were analyzed using log-linear regression as the results were
normally distributed. For the remaining outcome measures (ASES
shoulder score, CSS, OSS, UCLA shoulder score, and SPONSA),
Poisson regression was used. These models fit the data well as the
ratio of the Deviance to degrees of freedom, Value divided by degrees
of freedom, was about 1. Estimates and 95% confidence intervals
were exponentiated to give an incidence rate ratio and correspond-
ing 95% confidence interval. Reliability studies were performed using
Stata Statistical Software (release 14; StataCorp, College Station,
TX, USA). All other analyses were performed with SAS software
(version 9.4; SAS Institute, Cary, NC, USA).
Results
The cohort demographic data are presented in Tables S1 and
S2. Because of the relatively low numbers recorded in some
ethnic groups, no statistically significant comparisons could
be made between the individual ethnic groups. When com-
paring white participants versus participants of other ethnicities,
we found no significant differences (Table I).
A history of an inactive shoulder problem was reported
in 14.6% of Australians and 17% of Canadians (P = .16). Par-
ticipants with a history of an inactive shoulder problem had
poorer scores than those with no such history (Table II). This
was statistically significant for all scores except the CSS. A
current elbow or wrist problem (Table III) and handedness
(Table IV) were not associated with differences in any scores.
When we compared sexes, women reported similar or
poorer PROM scores for all PROMs assessed. However, when
we controlled for geographical location and age, only 3 were
statistically significant (ASES, CSS, and SPADI; Table V).
As age increased, PROM scores were poorer in all cat-
egories (Figs. 1 and S1).
PROM scores between geographical locations are pre-
sented in Figures 2-7 and Tables S3-S8. There were no
statistically significant differences in PROM scores reported
Table I Comparison of shoulder scores in white participants







ASES 96 96 .7077
CSS 87 88 .2681
OSS 47 47 .8457
UCLA 29 29 .4506
SPADI 3.7 4.3 .6749
SPONSA 95 95 .8408
ASES, American Shoulder and Elbow Surgeons; CSS, Constant-Murley Shoul-
der Score; OSS, Oxford Shoulder Score; UCLA, University of California,
Los Angeles; SPADI, Shoulder Pain and Disability Index; SPONSA, Stanmore
Percentage of Normal Shoulder Assessment.
Table II Comparison of shoulder scores in participants with
history of shoulder problem more than 3 years ago that has re-











ASES 96.7 93.9 .0003
CSS 87.2 85.6 .1521
OSS 46.8 46.1 .0013
UCLA 28.9 28.3 .0005
SPADI 3.3 6.1 <.0001
SPONSA 94.3 92.3 .0116
ASES, American Shoulder and Elbow Surgeons; CSS, Constant-Murley Shoul-
der Score; OSS, Oxford Shoulder Score; UCLA, University of California,
Los Angeles; SPADI, Shoulder Pain and Disability Index; SPONSA, Stanmore
Percentage of Normal Shoulder Assessment.
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between Canadians and Australians for the CSS and SPONSA
(Tables S4 and S8, respectively), as well as for the OSS in
all age brackets younger than 80 years (Table S5). A statis-
tically significant difference was reported between Canadians
and Australians for ASES, UCLA, and SPADI scores
(Tables S3, S6, and S7, respectively). Correlation between
PROMs is presented in Table VI.
Discussion
It is an important goal to differentiate normal, age-related
changes in shoulder function from those changes associated
with shoulder pathology; surgical intervention; or implant wear,
fatigue, or failure. An important step toward this goal is es-
Table III Comparison of shoulder scores in participants with











ASES 96.3 92.6 .8159
CSS 86.9 90.1 .3369
OSS 46.7 46.4 .5870
UCLA 28.8 28.4 .2578
SPADI 3.8 3.0 .9169
SPONSA 93.9 96.1 .5920
ASES, American Shoulder and Elbow Surgeons; CSS, Constant-Murley Shoul-
der Score; OSS, Oxford Shoulder Score; UCLA, University of California,
Los Angeles; SPADI, Shoulder Pain and Disability Index; SPONSA, Stanmore
Percentage of Normal Shoulder Assessment.
Table IV Comparison of shoulder scores by handedness
Mean score
Right handed Left handed P value
ASES 96 98 .2490
CSS 87 88 .4088
OSS 47 47 .5378
UCLA 29 29 .6150
SPADI 3.6 3.2 .7388
SPONSA 94 96 .1574
ASES, American Shoulder and Elbow Surgeons; CSS, Constant-Murley Shoul-
der Score; OSS, Oxford Shoulder Score; UCLA, University of California,
Los Angeles; SPADI, Shoulder Pain and Disability Index; SPONSA, Stanmore
Percentage of Normal Shoulder Assessment.
Table V Comparison of shoulder scores by sex adjusting for
nationality
Mean score
Men Women P value
ASES 97 95 .0303
CSS 90 84 <.0001
OSS 47 47 .4903
UCLA 29 28 .4768
SPADI 2.7 4.2 .0262
SPONSA 94 94 .7218
ASES, American Shoulder and Elbow Surgeons; CSS, Constant-Murley Shoul-
der Score; OSS, Oxford Shoulder Score; UCLA, University of California,
Los Angeles; SPADI, Shoulder Pain and Disability Index; SPONSA, Stanmore
Percentage of Normal Shoulder Assessment.












<30 30-39 40-49 50-59 60-69 70-79 80+
ASES OSS SPADI SPONSA UCLA CSS
Figure 1 Patient reported-outcome measure (PROM) scores com-
pared against age for each PROM investigated. ASES, American
Shoulder and Elbow Surgeons; OSS, Oxford Shoulder Score; SPADI,
Shoulder Pain and Disability Index; SPONSA, Stanmore Percent-
age of Normal Shoulder Assessment; UCLA, University of California,
Los Angeles; CSS, Constant-Murley Shoulder Score.
Figure 2 Scattergram and average American Shoulder and Elbow
Surgeons (ASES) shoulder score by nationality and age group. The
data lines are trend lines for the average score per age group. The
red line represents Canada and the green line represents Australia.
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tablishing a PROM reference database for individuals without
shoulder disease so that clinicians can effectively evaluate the
efficacy of treatments in patients on a longitudinal basis.
A recent review identified 44 outcome scores for the
shoulder.21 Many are used inappropriately or modified and
not tested for validity, reproducibility, or sensitivity to change.
Full validation of a scoring system is essential before it can
be recommended for clinical or research use. There remain
methodologic inconsistencies and difficulties with some widely
used scores.21
This study assessed 6 commonly used shoulder PROMs
in pathology-free individuals. Of these, the ASES shoulder
score, OSS, SPADI, and SPONSA contain subjective-only
patient reports of shoulder function. These PROMs have the
theoretical advantage of potentially being remotely admin-
istered, as they do not require a face-to-face interaction with
Figure 3 Scattergram and average Constant-Murley Shoulder Score
(CSS) by nationality and age group. The data lines are trend lines
for the average score per age group. The red line represents Canada
and the green line represents Australia.
Figure 4 Scattergram and average Oxford Shoulder Score (OSS)
by nationality and age group. The data lines are trend lines for the
average score per age group. The red line represents Canada and
the green line represents Australia.
Figure 5 Scattergram and average University of California, Los
Angeles (UCLA) shoulder score by nationality and age group. The
data lines are trend lines for the average score per age group. The
red line represents Canada and the green line represents Australia.
Figure 6 Scattergram and average Shoulder Pain and Disability
Index (SPADI) by nationality and age group. The data lines are trend
lines for the average score per age group. The red line represents
Canada and the green line represents Australia.
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an assessor. In comparison, the CSS and UCLA shoulder
score have both subjective and clinician-derived objective com-
ponents to their scoring. These 2 assessment tools require
additional time, resources, and personnel to administer (in-
cluding a face-to-face interaction with an assessor). This study
assessed for correlation between the 6 shoulder PROMs, as
well as for differences between the PROMs, in relation to sex,
age, ethnicity, and geographical location. An important aspect
of the analysis was to determine whether there were differ-
ences identified between the subjective-only PROMs and the
subjective-objective PROMs. Potential benefits exist if there
is no reported difference in subjective-only PROMs, as these
may be administered remotely, without the need for a face-
to-face interaction.
This study reports a statistically significant correlation
between all assessment tools, with no difference identified
when comparing subjective-only PROMs with combined
subjective-objective PROMs. The highest reported correla-
tion was between the OSS (subjective only) and UCLA score
(combined subjective and objective). This finding suggests
there may be no advantage in using a combined subjective-
objective assessment tool. As resource management and
cost justification are becoming more of a focus for our in-
stitutions, consideration should be given to a shoulder PROM
tool that is equivalent but does not require an objective as-
sessment component. Further research is required to determine
whether this finding applies to a pathologic shoulder cohort,
especially because the collection of objective data requires
additional resources, personnel, and expertise to complete.
An association between a history of inactive shoulder
pathology and poorer PROM values was seen, with the total
numbers of participants having reported such a history being
relatively high (15.3%). With increasing age category, the pro-
portion of participants reporting an inactive history increased,
as did the proportion of participants with a history of dom-
inant shoulder surgery (>3 years ago) who were asymptomatic
(Table VII). Overall, even proportions of Canadian and
Australian participants reported inactive shoulder patholo-
gy; however, as age increased, more Canadians had a positive
history. Although it is logical that with increasing age, more
persons would have a history of asymptomatic shoulder pa-
thology, it is possible that a selection bias may have contributed
to this finding. Certainly, a history of inactive shoulder pa-
thology should be taken into consideration when choosing
an asymptomatic “control” group to compare against an
interventional group.
When we compared all PROMs, there was no statistical-
ly significant association between PROM score and a current
elbow or wrist problem. This finding supports the conclu-
sion that these 6 shoulder PROMs are specific to the shoulder
and can discriminate pathology with the shoulder as its primary
source from other sources of upper-limb incapacity. Al-
though it is possible that a participant with a current elbow
or wrist problem may have had overlapping upper-limb issues
that could have influenced some (or all) of his or her re-
sponses, the results did not support this. Further research is
required to determine whether this finding applies to a patho-
logic shoulder cohort.
In this study, shoulder data were collected electronically
from 2 asymptomatic, distinct, remote, Westernized popula-
tions of different geographical locations that were
representative of their local populations.1,11 To our knowl-
edge, this has not been investigated previously. The slightly
higher proportion of persons of European descent (white
participants by default) represented in the Australian cohort
is consistent with that reported by the Australian Bureau of
Statistics.1 The higher proportions of Chinese, Middle Eastern,
and Asian Indians represented in the Canadian cohort are
consistent with those reported by Statistics Canada.11 Al-
though there was a difference observed between the cohorts
regarding ethnicity, the numbers were too small to allow for
any statistical assessment.
A trend for female participants to report similar or poorer
overall PROM scores was found for all PROMs assessed.
However, not all of the PROMs investigated were statisti-
cally significant. This finding is similar to findings of other
studies that have reported poorer CSS6,16 and OSS6 asymp-
tomatic scores associated with female sex. This finding differs
from that of a study assessing asymptomatic shoulder ASES
scores in young, active adults, which reported no difference
when assessing sex.3 Our study had a larger distribution of
ages and a higher proportion of elderly participants, and this
may explain the differences reported in the literature. Further
research is required to assess whether this study’s finding is
a trend or represents a true difference.
Our study found an inverse correlation between age and
reported PROM (ie, as age increases, the reported PROM
score is poorer). This finding is not surprising given the
Figure 7 Scattergram and average Stanmore Percentage of Normal
Shoulder Assessment (SPONSA) by nationality and age group. The
data lines are trend lines for the average score per age group. The
red line represents Canada and the green line represents Australia.
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age-related changes that occur over time, as well as the ac-
cumulated medical and surgical comorbidities that can affect
shoulder function. Very few studies exist that have reported
associations between shoulder PROMs and age, with a few
studies reporting poorer CSS in older age groups.6,16
In addition to the inverse correlation between age and re-
ported PROM, a large variation in PROM values was reported
in individuals aged 80 years or older. These poorer PROM
reports were more pronounced in the Canadian cohort aged
80 years or older compared with their Australian equiva-
lents. This trend is well demonstrated when comparing each
PROM graph, where national PROMs become more diver-
gent in individuals aged 80 years or older (Figs. 2-7). This
finding may represent a true difference between the Austra-
lian and Canadian populations or may represent a selection
bias. Certainly, this finding suggests that there are likely many
other determinants of health and function that may influ-
ence the subjective and objective scores reported and possibly
the accuracy of “asymptomatic” values in this older age group.
No difference in OSS values for participants younger than
79 years was found (Table S5). The greatest variation in OSS
values was recorded in the group aged 80 years or older, with
some respondents in this subgroup recording OSS values of
48 out of 48 (even up to 90 years [OSS range, 27-48 out of
48]). Overall, this study suggests that PROM values are highly
variable in individuals aged 80 years or older, making com-
parisons in this older age group less reliable. Care should be
taken when interpreting these data and applying generaliza-
tions to different populations in geographically distinct
locations (especially in individuals aged ≥80 years).
There were comparable CSS and SPONSA values between
the national cohorts. This finding suggests that future studies
using the CSS and/or SPONSA and a control group can be
more easily generalized against populations, independent of
the study country of origin. Further studies need to be com-
pleted to determine whether this principle applies to other
countries that use an electronic database.
Our study found a statistically significant difference between
the Canadian and Australian cohorts for the ASES, UCLA,
and SPADI scores. This finding is difficult to interpret and
may reflect a true difference between the population cohorts—
or a selection or reporting bias. We recommend that future
studies using the ASES, UCLA, and SPADI scores should
perform comparisons against a control group sourced from
the same country of origin and be age and sex matched.
To our knowledge, this study represents the largest data-
base of nonpathologic shoulder PROM values reported in the
literature. Other researchers have reported asymptomatic values
for some of the PROMs examined in this study, but few have
approached the numbers collected in this study or the par-
ticipants were limited to young, active individuals.3,4,6,16,24,26
To our knowledge, there exist no data in the literature re-
porting nonpathologic shoulder PROM values for the SPADI
or SPONSA shoulder scores.
Several studies have reported that the theoretically best
shoulder score may not be reported in an asymptomatic
and disease-free population.2,3,14,16,24,26 However, very few have
examined the effect of age, sex, hand dominance, race, or
geographical location on shoulder PROM scores in pathology-
free individuals. No other study has compared 6 shoulder
PROMs in “asymptomatic” individuals of all ages.
This study has important limitations that should be con-
sidered when interpreting the results. As with any observational
Table VI Comparison of patient-reported outcome assessments using Spearman correlation coefficients (P value) to assess for correlation































ASES, American Shoulder and Elbow Surgeons; CSS, Constant-Murley Shoulder Score; OSS, Oxford Shoulder Score; UCLA, University of California, Los Angeles;
SPONSA, Stanmore Percentage of Normal Shoulder Assessment; SPADI, Shoulder Pain and Disability Index.
A correlation coefficient of 0.7 or greater is considered very strong; 0.4-0.69, strong; 0.3-0.39, moderate; 0.2-0.29, weak; and 0.01-0.19, negligible.
Table VII Demographic data: history of shoulder surgery and





Australia Canada Australia Canada
<30 y 0.0 0.0 15.4 3.0
30-39 y 0.0 0.0 6.3 3.1
40-49 y 0.0 2.0 13.5 21.6
50-59 y 1.4 2.7 13.7 20.5
60-69 y 1.4 4.3 20.8 20.3
70-79 y 0.0 7.0 9.5 25.6
≥80 y 0.0 18.2 23.1 54.5
312 J.M. McLean et al.
study, there is the potential for selection bias, particularly when
there is no randomization. The primary benefit of random-
ization is the elimination of both conscious and unconscious
bias associated with the selection of a participant. Although
individuals were approached randomly in this study, no spe-
cific randomization method of participant identification was
used. Another potential source of selection bias involves the
use of electronic questionnaires, in which case participants
may have declined to be involved because of the technolo-
gy. Anecdotally, several elderly participants were initially
reluctant to be involved but agreed to participate with an as-
sessor helping complete the electronic questionnaires. This
may have introduced interviewer bias.
Participants with a history of inactive shoulder patholo-
gy may have chosen not to participate in the study, citing
that their shoulder was not “normal.” Although we chose to
exclude participants with active shoulder disease, we did
include participants with a history of a previous shoulder
problem that “no longer bothered them.” As this is a purely
subjective report, it is possible that some of those individu-
als who had a prior shoulder problem may have had only
minor functional incapacities and should have been in-
cluded in the study. There was no difference reported between
the international cohorts in relation to a history of inactive
shoulder pathology. As no radiographs or ultrasound scans
were taken to confirm whether participants had asymptom-
atic shoulder disease, it is possible that some of these
individuals were included in the cohorts.
The adoption of electronic, automated PROM data col-
lection relies on the assumption that a patient prefers this virtual
method of follow-up in preference to a face-to-face clinician-
patient interaction. It also assumes that a patient is capable
of and willing to be actively participating independently in
his or her management. It also requires the patient to be com-
puter and E-mail savvy, an assumption that may not be correct
for the entire population. This method of electronic data col-
lection has the potential advantage of allowing remote follow-
up and, for research purposes, enables data collection at an
international level.
Conclusion
An electronic PROM data collection system can be used
effectively across different continents. Differences in sex,
age, and geographical location will affect PROM shoul-
der scores in pathology-free individuals and should be
taken into consideration when PROMs are being used to
compare patient outcomes. This study has established
normative values for the ASES shoulder score, CSS,
OSS, UCLA shoulder score, SPADI score, and SPONSA.
Future studies assessing a pathologic patient cohort should
perform comparisons against a sex- and age-matched
control cohort, ideally sourced from their same country
of origin.
Disclaimer
The individual research tool registrations were paid for
by OBERD Pty Ltd and are included as part of the li-
censing agreement.
The authors, their immediate families, and any re-
search foundations with which they are affiliated have not
received any financial payments or other benefits from any
commercial entity related to the subject of this article.
Acknowledgments
We acknowledge Mami Okada, University of British Co-
lumbia, for her help in the establishment of the study in
Canada; Tara-Louise McLean, research assistant to J.M.M.,
for her help in the establishment of the study in Australia
and Canada; Suzanne Edwards, statistician, Data Man-
agement and Analysis Centre at the University of Adelaide,
for her help with the statistical analysis of the collected
data; Tiffany Gill, University of Adelaide, for her help
with the study design; and Catherine Hill, University of
Adelaide, for her help with the study design.
Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.jse.2017.08.016.
References
1. Australian Bureau of Statistics. Cultural diversity in Australia. Vol ABS
catalogue number 2071.0. Canberra. <http://www.abs.gov.au/ausstats/
abs@.nsf/mf/2071.0>; 2011, accessed September 30, 2016.
2. Brinker MR, Cuomo JS, Popham GJ, O’Connor DP, Barrack RL. An
examination of bias in shoulder scoring instruments among healthy
collegiate and recreational athletes. J Shoulder Elbow Surg 2002;11:463-
9. http://dx.doi.org/10.1067/mse.2002.126209
3. Clarke MG, Dewing CB, Schroder DT, Solomon DJ, Provencher MT.
Normal shoulder outcome score values in the young, active adult. J
Shoulder Elbow Surg 2009;18:424-8. http://dx.doi.org/10.1016/j.jse.2008
.10.009
4. Clement ND, Court-Brown CM. Oxford shoulder score in a normal
population. Int J Shoulder Surg 2014;8:10-4. http://dx.doi.org/10.4103/
0973-6042.131849
5. Conboy VB, Morris RW, Kiss J, Carr AJ. An evaluation of the Constant-
Murley shoulder assessment. J Bone Joint Surg Br 1996;78:229-32.
6. Constant CR, Gerber C, Emery RJ, Søjbjerg JO, Gohlke F, Boileau P.
A review of the Constant score: modifications and guidelines for its
use. J Shoulder Elbow Surg 2008;17:355-61. http://dx.doi.org/10.1016/
j.jse.2007.06.022
7. Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA,
et al. Recommendations on evidence needed to support measurement
equivalence between electronic and paper-based patient-reported outcome
(PRO) measures: ISPOR ePRO Good Research Practices Task Force
report. Value Health 2009;12:419-29. http://dx.doi.org/10.1111/j.1524
-4733.2008.00470.x
Shoulder clinical scores in pathology-free individuals 313
8. Dawson J, Fitzpatrick R, Carr A. The assessment of shoulder instability.
The development and validation of a questionnaire. J Bone Joint Surg
Br 1999;81:420-6.
9. Dawson J, Fitzpatrick R, Carr A. Questionnaire on the perceptions
of patients about shoulder surgery. J Bone Joint Surg Br 1996;78:593-
600.
10. Dawson J, Rogers K, Fitzpatrick R, Carr A. The Oxford shoulder score
revisited. Arch Orthop Trauma Surg 2009;129:119-23. http://dx.doi.org/
10.1007/s00402-007-0549-7
11. Government of Canada. Ethnic origins for Canada, provinces and
territories Calgary. <http://www12.statcan.ca/census-recensement/2011/
as-sa/98-310-x/98-310-x2011001-eng.cfm>; 2011, accessed September
30, 2016.
12. Greenhalgh J. The applications of PROs in clinical practice: what are
they, do they work, and why? Qual Life Res 2009;18:115-23.
http://dx.doi.org/10.1007/s11136-008-9430-6
13. Griffiths-Jones W, Norton MR, Fern ED, Williams DH. The equivalence
of remote electronic and paper patient reported outcome (PRO) collection.
J Arthroplasty 2014;29:2136-9. http://dx.doi.org/10.1016/j.arth.2014
.07.003
14. Hunsaker FG, Cioffi DA, Amadio PC, Wright JG, Caughlin B. The
American academy of orthopaedic surgeons outcomes instruments:
normative values from the general population. J Bone Joint Surg Am
2002;84:208-15.
15. James MA. Use of the Medical Research Council muscle strength grading
system in the upper extremity. J Hand Surg Am 2007;32:154-6.
http://dx.doi.org/10.1016/j.jhsa.2006.11.008
16. Katolik LI, Romeo AA, Cole BJ, Verma NN, Hayden JK, Bach BR.
Normalization of the Constant score. J Shoulder Elbow Surg
2005;14:279-85. http://dx.doi.org/10.1016/j.jse.2004.10.009
17. Kocher MS, Horan MP, Briggs KK, Richardson TR, O’Holleran J,
Hawkins RJ. Reliability, validity, and responsiveness of the American
Shoulder and Elbow Surgeons subjective shoulder scale in patients with
shoulder instability, rotator cuff disease, and glenohumeral arthritis. J
Bone Joint Surg Am 2005;87:2006-11. http://dx.doi.org/10.2106/JBJS.C
.01624
18. MacDermid JC, Solomon P, Prkachin K. The Shoulder Pain and
Disability Index demonstrates factor, construct and longitudinal validity.
BMC Musculoskelet Disord 2006;7:12. http://dx.doi.org/10.1186/1471
-2474-7-12
19. Maréchal E. Ruptures degeneratives de la coiffe des rotateurs de
l’épaule. Evaluation fonctionnelle resultats du traitement chirurgical.
Lyon, France: Faculté de Médecine Grange, Université Claude Bernard;
1990.
20. Mitchell K, Gutierrez SB, Sutton S, Morton S, Morgenthaler A.
Reliability and validity of goniometric iPhone applications for the
assessment of active shoulder external rotation. Physiother Theory
Pract 2014;30:521-5. http://dx.doi.org/10.3109/09593985.2014
.900593
21. Noorani AM, Roberts DJ, Malone AA, Waters TS, Jaggi A, Lambert
SM, et al. Validation of the Stanmore Percentage of Normal Shoulder
Assessment. Int J Shoulder Surg 2012;6:9-14. http://dx.doi.org/10.4103/
0973-6042.94307
22. Richards RR, An KN, Bigliani LU, Friedman RJ, Gartsman GM, Gristina
AG, et al. A standardized method for the assessment of shoulder function.
J Shoulder Elbow Surg 1994;3:347-52.
23. Roach KE, Budiman-Mak E, Songsiridej N, Lertratanakul Y.
Development of a shoulder pain and disability index. Arthritis Care Res
1991;4:143-9.
24. Sallay PI, Reed L. The measurement of normative American Shoulder
and Elbow Surgeons scores. J Shoulder Elbow Surg 2003;12:622-7.
http://dx.doi.org/10.1016/S1058-2746(03)00209-X
25. Smith MJ, Marberry KM. Reliability of a novel, web-based, shoulder-
specific, patient-reported outcome instrument. Curr Orthop Pract
2013;24:64-7. http://dx.doi.org/10.1097/BCO.0b013e3182781c05
26. Soldatis JJ, Moseley JB, Etminan M. Shoulder symptoms in healthy
athletes: a comparison of outcome scoring systems. J Shoulder Elbow
Surg 1997;6:265-71.
314 J.M. McLean et al.
 62 
CHAPTER 5 – ASYMPTOMATIC REFERENCE VALUES FOR THE DASH AND PRWHE – 
ELECTRONIC DATA COLLECTION AND ITS CLINICAL IMPLICATIONS  
As published in Journal of Hand Surgery: European Volume. 2018. Nov; 43 (9): 988-993. 
Introduction 
The efficacy of medical and surgical treatments for wrist and hand disorders, are commonly assessed 
using Patient Reported Outcome Measures (PROMs). Several wrist and hand PROMs have been 
described and validated, with the Disability of Arm, Shoulder and Hand (DASH) questionnaire (12) and 
Patient-Rated Wrist/Hand Evaluation (PRWHE) (11), being investigated in this thesis. Accurate 
interpretation of PROMs requires an understanding of patient factors that have the potential to impact 
scores; such as previous or current injury or surgery, age, gender, handedness, ethnicity and 
geographical location. 
Aims 
The aim of this study was to assess whether the DASH and PRWHE scores were comparable in 
normal, healthy, pathology-free individuals of different age, gender, ethnicity, handedness, history of 
pathology and nationality. The purpose of this study was to establish a data bank of “normal” population 
values for the DASH and PRWHE upper limb scores. The hypothesis was that there is no difference in 
reported DASH and PRWHE values in an asymptomatic “normal” population, when comparing sub-
groups of differing age, gender, ethnicity, handedness, history of pathology and different nationality. 
Main Findings 
This study of 584 participants represents the only available data on normative PRWHE values in the 
literature. It also represents one of the largest databases of normative DASH values reported in the 
literature (73-75). No other study has compared upper limb PROM scores from normal, pathology-free 
individuals from international cohorts, or collected them remotely and electronically via the same 
research database. 
 
This study found that there was an association between the DASH and age and the PRWHE and age, 
demonstrating that as age increased, reported PROM scores were poorer.  
 
Females reported poorer DASH and PRWHE scores compared to males, which was more evident as 
age increased. This finding was consistent with previous studies that reported poorer DASH scores in 
asymptomatic, “normal” females (74, 76, 77). Poorer PRWHE scores for females has not previously been 
reported in an asymptomatic cohort.  
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There was no difference in the two reported PROM scores when considering handedness or 
geographical location. Twelve percent of participants reported a history of an inactive wrist or hand 
problem, which was associated with 10.5% poorer reported PROM score, compared to those who had 
no such history. This seems logical and suggests that a history of an inactive wrist or hand problem 
should be taken into consideration when choosing an asymptomatic “control” group to compare against 
an interventional group. 
 
Participants who reported a history of an active shoulder or elbow problem, reported poorer PROM 
scores compared to those who had no such history. This finding supports the contention that there may 
be considerable overlap in the functional questions contained in the two PROMs investigated. This 
suggests that the DASH and PRWHE cannot discriminate a primarily wrist- or hand-source of pathology 
from other sources of upper limb incapacity. This should be considered when using these PROMs in 
patients with multiple, concurrent upper limb pathologies  
Future directions 
Studies using an electronic control group should consider differences in gender, age, ethnicity, 
handedness, history of pathology and nationality, when using wrist and hand PROMs to assess patient 
outcomes. This study has established an electronic, “normal” control group for studies using the DASH 
and PRWHE PROMs. When using these PROMs, the control group can be sourced from a pre-
established control group within an existing database, without necessarily being sourced from the same 
country of origin. Care should be taken when using the DASH and PRWHE PROMs in patients with 
multiple, concurrent upper limb pathologies, or in patients with a history of an inactive wrist or hand 
problem, as these factors are likely to impact on the PROM values reported. 
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Asymptomatic reference values for
the Disability of Arm, Shoulder and
Hand and Patient-Rated Wrist/Hand
Evaluation – electronic data collection
and its clinical implications
James M. McLean1,2, Afsana P. Hasan2, Jake Willet2,
Matthew Jennings2, Kimberly Brown3, Laura Goodwins3
and Tom Goetz1
Abstract
The purpose of this study was to establish normal asymptomatic population values for the Disability of Arm,
Shoulder and Hand and Patient-Rated Wrist/Hand Evaluation in healthy, asymptomatic individuals of different
age, gender, ethnicity, handedness and nationality, using electronic data collection. Two-hundred and ninety-
two Australian and 293 Canadian citizens with no active wrist pain, injury or pathology in their dominant hand,
were evaluated. Participants completed an electronically administered questionnaire and were assessed
clinically. There was no statistically significant association between both wrist scores and nationality.
There was a statistically significant association between both wrist scores and age, demonstrating that as
age increased, normal wrist function declined. This study has established an electronic, asymptomatic control
group for future studies using these scores. When using the Disability of Arm, Shoulder and Hand and Patient-
Rated Wrist/Hand Evaluation, the control group can be sourced from a pre-established control group within a
database, without necessarily being sourced from the same country of origin.
Level of evidence: II
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Introduction
The efficacy of current and future medical and surgi-
cal treatments for wrist and hand disorders can be
evaluated with outcome assessments tools. Pre- and
post-operative Patient-Reported Outcome Measures
(PROMs) are important tools in assessing a patient’s
suitability for surgery, expected outcome and post-
operative recovery. PROMs data can be collected and
processed electronically, enabling faster processing
with minimal clinician input (Griffiths-Jones et al.,
2014). Accurate interpretation of PROMs requires
an understanding of patient factors that have the
potential to impact scores, such as previous or cur-
rent injury, age, gender, handedness, ethnicity and
nationality.
The Disability of Arm, Shoulder and Hand (DASH)
questionnaire and Patient-Rated Wrist/Hand
Evaluation (PRWHE) were chosen for this study
because they both demonstrate good reliability,
validity and responsiveness (Beaton et al., 2001;
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Changulani et al., 2008; Gay et al., 2003; Hoang-Kim
et al., 2011; MacDermid, 2001; MacDermid et al.,
2000).
The purpose of this study was to establish asymp-
tomatic population values for the DASH and PRWHE,
using an electronic data collection system. These
novel data systems will support more accurate inter-
pretations of outcome assessments and allow for
direct comparison to age- and gender-matched
individuals, or a comparison with individuals with
specific characteristics.
Our hypothesis was that there is no difference in
DASH and PRWHE values in a normal population




With prior Research Ethics Board approval, between
November 2014 to October 2015, healthy volunteers
were recruited in Australia and Canada from a variety
of sources, including Drivers Licensing Offices,
Medical Outpatients Facilities and various community
centres. There were no study advertisements or
incentives and participants were not paid.
The inclusion criteria included: English-speaking
adults with no reported active wrist or hand path-
ology in either hand. Participants were directed to
answer their questionnaires in relation to their dom-
inant hand. Potential participants self-reported a
history of dominant hand pain or pathology; no
medical charts or radiographs were reviewed to cat-
egorize asymptomatic participants.
Exclusion criteria included: cognitive impairment;
a history of inflammatory or wrist arthritis; signifi-
cant cervical spine problems that interfered with
their function; active wrist or hand pathology, surgi-
cal arthrodesis or arthroplasty; or wrist or hand
surgery within the past 3 years.
A history of inactive wrist or hand pathology,
including previous surgery, was recorded. A history
of active shoulder and elbow pathology was recorded.
Data collection
Participants self-administered 45 questions (DASH
30 questions and PRWHE 15 questions), using a
web-based data collection tool (OBERD, Universal
Research Solutions, Columbia, MO, USA), on an elec-
tronic mobile device (tablet or laptop computer). Data
handling by the recruiters was minimal, ensuring
that the investigators were partially blinded to the
participants’ results.
Primary outcome measures
The DASH score is a 30-item upper extremity out-
come assessment tool that assesses an individual’s
symptoms and functional status (Hudak et al., 1996).
Each item is scored between 1–5, and the maximum
score of 100 correlates with a high disability.
The PRWHE score is a 15-item wrist and hand
assessment tool that assesses an individual’s wrist
and hand pain (5 items) and function (10 items)
(MacDermid et al., 1998). Each item is scored
between 0–10 and the functional score is divided
by 2. The maximum score of 100 correlates with a
high disability.
Statistical analysis
A power calculation was performed to determine the
sample size necessary to detect a clinically signifi-
cant difference in wrist scores of 20% at a power of
80% and an alpha value of 0.05 (n = 280). Associations
between nationality, age, gender, handedness and
ethnicity were investigated using chi-square and
Fisher’s Exact Test where appropriate. Poisson
regression models were used to investigate the asso-
ciation between wrist scores and these variables.
Linear regression was not performed because resi-
duals from a linear model were very left-skewed, as
were the residuals using a logarithmic transform of
the outcome variable. Wrist scores were therefore
considered to be counts. Poisson regressions were
performed and ranged from 0.0124 to 3.1994.
Confidence interval (CI) was set at 95% for a two-
way mixed effects model and absolute agreement.
Initially country cohort and all confounders were
included in a multivariable Poisson regression
model for each wrist score outcome variable.
Backwards stepwise elimination was then performed
until all covariates had a p value <0.2.
Results
Two-hundred and ninety-two Australian and 293
Canadian citizens with no active wrist pain, injury or
pathology in their dominant hand completed the
questionnaire. Demographics of the cohorts are pre-
sented in Tables 1 and 2. The effect of a history of
inactive wrist/hand problem or an active shoulder
and/or elbow problem on a participant’s PROM
scores are presented in Table 3.
DASH
There was a statistically significant association
between the DASH and age (p< 0.0001, EE = 0.06,
95% CI = 0.02, 0.22). For every 1-year increase in
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age, the mean DASH value increased by 3.3%
(p< 0.0001; Table 4; Supplemental Figure S1).
There was no statistically significant association
between the DASH and handedness (p = 0.5841) or
nationality (adjusting for age (p = 0.8790) and adjust-
ing for gender (p = 0.7715)). Australians reported
DASH values 1.3% lower than Canadians, which
was not statistically significant. There was a statis-
tically significant association between DASH and
gender (p< 0.0001, EE = 2.41, 95% CI = 1.65, 3.52).
The mean DASH value for females was 7.8 compared
with 3.2 for males, with females reporting a mean
DASH score 2.4 times that of males.
PRWHE
There was a statistically significant association
between the PRWHE and age (p< 0.0001, EE = 0.53,
95% CI = 0.38, 0.72). For every 1-year increase in age,
the mean PRWHE value increased by 2.3%
(p< 0.0001; Table 5; Supplemental Figure S2).
There was no statistically significant association




(n = 293) Total (n = 585)
Comparing Australian
and Canadian cohorts
Male 140 (48.9%) 140 (47.8%) 280 (47.8%) p = 0.10
Female 152 (52.1%) 153 (52.2%) 305 (52.2%)
Left 29 (9.9%) 30 (10.2%) 59 (10.1%) p = 0.86
Right 263 (90.1%) 263 (89.8%) 526 (89.9%)
Age< 30 35 (12%) 33 (11.2%) 68 (11.6%) p = 0.84
Age 30–39 34 (11.9%) 37 (12.6%) 71 (12.1%)
Age 40–49 50 (17.1%) 51 (17.4%) 101 (17.3%)
Age 50–59 62 (21.2%) 65 (22.2%) 127 (21.7%)
Age 60–69 66 (22.6%) 65 (22.2%) 131 (22.4%)
Age 70–79 23 (7.8%) 22 (7.5%) 45 (7.7%)
Age 80þ 18 (6.1%) 20 (6.8%) 38 (6.5%)
Average age 53 (range 18–94) 53 (range 18–96) 53 (range 18–96)
Privately insured 148 (50.7%) 0 (0.0%)
Publicly insured 144 (49.3%) 293 (100.0%)
Participant reported
a history of an inactive
(previous) wrist or
hand problem
36 (12.1%) 38 (12.9%) 74 (12.6%) p = 0.77
Participant reported a
history of an active
shoulder or elbow problem
18 (6.1%) 29 (9.8%) 47 (8%) p = 0.09
Table 1. A comparison of ethnicity of the two international cohorts.
Ethnicity Australia (n = 291) Canada (n = 293) Total (n = 584)
Caucasian 258 (88.7%) 217 (74.0%) 276 (83.4%)
Chinese 9 (3.1%) 20 (6.8%) 29 (4.9%)
Asian Indian 6 (2.1%) 18 (6.1%) 24 (4.1%)
Middle Eastern 5 (1.7%) 17 (5.8%) 22 (3.7%)
Other Asian 5 (1.7%) 9 (3.1%) 14 (2.4%)
Filipino 5 (1.7%) 8 (2.7%) 13 (2.2%)
Indigenous 2 (<1%) 3 (1.1%) 5 (<1%)
African American 1 (<1%) 1 (<1%) 2 (<1%)
990 Journal of Hand Surgery (Eur) 43(9)
between PRWHE and handedness (p = 0.4049) or
nationality (adjusting for age (p = 0.6769) and adjust-
ing for gender (p = 0.7369)). Australians reported
PRWHE values 0.4% higher than Canadians, which
was not statistically significant. There was a statis-
tically significant association between PRWHE and
gender (p< 0.0001, EE = 2.1, 95% CI = 1.5, 3.1). The
mean PRWHE value for females was 8.6 compared
with 4.1 for males, with females reporting a mean
PRWHE score 2.1 times that of males.
Discussion
This study established a reference database of norma-
tive values for individuals without wrist or hand
conditions, to evaluate the efficacy of surgical, non-
surgical and hand therapy interventions longitudinally.
DASH and PRWHE values were comparable between
national cohorts (Tables 4 and 5). This suggests that
future international studies using these tools can be
performed using a combined control group, without
necessarily needing to be sourced from the same
country of origin as the proposed study. This can
enable larger, combined sample sizes to be used in
the assessment of future interventions.
In this study, data was collected electronically
from two normal, distinct, remote, Westernized
populations of different countries, that were repre-
sentative of their local populations (Australian
Bureau of Statistics, 2011; Canada Statistics, 2011).
The DASH and PRWHE assessment tools were
chosen, as they are both subjective scores, allowing
them to be administered remotely and electronically
at low cost.
A positive relationship was observed between age
and the DASH and PRWHE score reported, indicating
that as age increases, the degree of baseline, non-
pathological disability increases. This finding was
consistent with other PROM studies (Aasheim and
Finsen, 2014; Hunsaker et al., 2002; Jester et al.,
2005; Klum et al., 2012) and likely indicates that
age-related changes (i.e. degeneration and loss of
strength) and the accumulation of medical and sur-
gical comorbidities influence upper limb function.
Among the younger population (aged below 30), the
average scores were not as close to perfect as
expected. This finding suggests that an excellent
DASH or PRWHE score may not reflect a realistic
or achievable goal in each individual patient (Clarke
et al., 2009) and a considered understanding of other
factors that can influence function are required for a
more accurate interpretation.
There was a significantly poorer reported score
among females compared with males across both
PROM tools. This has been previously described
only for the DASH in the general population
(Aasheim and Finsen, 2014; Hunsaker et al., 2002;
Jester et al., 2005).
Table 3. Average DASH and PRWHE scores in participants
with/without a history of an inactive wrist/hand problem
and participants with/without an active shoulder/elbow
problem.
DASH PRWHE
History of an inactive wrist/
hand problem
10.0 11.4
No history of a wrist/hand problem 4.9 5.6
Mean difference 5.1a 5.8b
Active shoulder and/or elbow problem 21.3 21.1
No active shoulder/elbow problem 4.2 5.1
Mean difference 17.1c 16d
aEE = 2.05, 95% CI = 1.55, 2.71, p< 0.01.
bEE = 2.05, 95% CI = 1.52, 2.75, p< 0.01.
cEE = 5.01, 95% CI = 4.04, 6.22, p< 0.001.
dEE = 4.13, 95% CI = 3.25, 5.27, p< 0.001.
(DASH) Disability of Arm, Shoulder and Hand; (PRWHE) Patient-
Rated Wrist/Hand Evaluation.
Table 4. Mean DASH scores by age for Australian and
Canadian cohorts, and the combined cohorts.
Age Australia Canada Combined
<30 1.44 0.49 0.97
30–39 2.00 1.09 1.54
40–49 3.31 2.02 2.67
50–59 3.94 5.23 4.60
60–69 4.88 6.37 5.63
70–79 10.60 15.99 13.30
80þ 20.64 27.68 24.35
Overall 4.99 6.22 5.61
DASH (lowest (best) score 0; highest (worst) score = 100).
Table 5. Mean PRWHE scores by age for Australian and
Canadian cohorts, and the combined cohorts.
Age Australia Canada Combined
<30 6.59 3.87 1.19
30–39 4.68 4.58 2.53
40–49 10.03 5.90 3.90
50–59 7.76 6.36 5.24
60–69 9.78 9.78 7.88
70–79 9.98 17.70 14.80
80þ 15.18 17.46 18.80
Overall 5.94 6.79 6.36
PRWHE (lowest (best) score 0; highest (worst) score = 100).
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This study reported an association between a his-
tory of inactive wrist or hand pathology and PROM
score (Table 3). This seems logical, and as such,
should be taken into consideration when choosing a
control group to compare against an interventional
group.
This study reported an association between a his-
tory of an active shoulder and/or elbow problem and
PROM score. As the DASH assesses the overall func-
tion of the upper limb, this finding was expected for
the DASH. However, for the PRWHE, there is consid-
erable overlap in the functional questions, which
suggests that it may not isolate wrist- and hand-
specific function and may fail to discriminate a pri-
marily wrist- and hand-source of pathology from
other sources of upper limb incapacity. This should
be considered when using the PRWHE in patients
with multiple, concurrent upper limb pathologies.
This study represents one of the largest databases
of combined asymptomatic population DASH and
PRWHE values reported in the literature. Thus far,
no other study has compared normal scores in inter-
national cohorts or collected them remotely and
electronically via the same research database. In
the literature, normative values have been collected
for the DASH (Table 6); these studies combined both
healthy participants with participants with disabil-
ities, likely resulting in a considerably higher average
mean score to that which was reported in this study.
There is no available data on normative PRWHE
values.
Previous studies have administered their ques-
tionnaires via mail, resulting in a variable response
rate ranging from 50% to 67% (Aasheim and Finsen,
2014; Hunsaker et al., 2002). An electronic database
facilitates much easier data collection at an inter-
national level. It enables easy and remote access of
data to clinical researchers, simultaneous data entry
and analysis, the linking of research PROMs to an
electronic medical record, the automated setting of
participant reminders and the setting of response
time points. It is more convenient for patients as
timing is flexible and there is no need to return the
survey by post. However, electronically administered
questionnaires require respondents to possess a
basic level of computer skills; an assumption that
may not be correct for all members of the public
(Snyder et al., 2012). Patients with severe wrist and
hand pathology may also be less willing to complete
online questionnaires via computers or tablets and
may require help to complete the surveys.
Limitations
As with any observational study, there is the potential
for selection bias. Although individuals were
approached randomly in this study, no specific
randomized method of recruitment was employed.
A potential source of procedural bias was the use
of electronic questionnaires, and elderly participants
may have declined to be involved due to the use of
technology. Radiographs were not performed to rule
out asymptomatic degenerative wrist disease and it is
possible that some individuals with asymptomatic
pathology were included. It is assumed that a small
percentage of the general population will have
asymptomatic or incidental undiagnosed wrist/hand
pathology. The Authors feel that the carefully chosen
inclusion and exclusion criteria in this study pro-
duced an asymptomatic population who identified
themselves as having ‘normal’ bilateral wrists and
hands.
Participants with a history of dominant hand path-
ology treated by non-arthroplasty/arthrodesis sur-
gery >3 years ago and no longer experiencing
symptoms were included. It is possible that some
of these participants still suffered from some slight
impairment; however, we only included those who no
longer perceived their condition to be a problem.
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Table 6. Normative DASH values reported in the literature.
Author, year N Cohort Mean
Hunsaker et al., 2002 1706 Randomly selected households in the United States 10
Aasheim and Finsen, 2014 1000 Randomly selected adults aged 20–80 years in Norway 13
Klum et al., 2012 750 Healthy, working volunteers aged 18–65 years in Germany 9
Jester et al., 2005 716 Employed adults in Germany 13
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Chapter 6 - CONCLUSIONS 
Discussion 
It is an important goal to differentiate normal, age-related changes in joint function from those changes 
associated with symptomatic pathology; surgical intervention; or implant wear, fatigue, or failure. A 
significant step toward this goal is the establishment of a joint-specific PROM reference database for 
individuals without joint disease, so that clinicians can effectively evaluate the efficacy of treatments in 
orthopaedic patients on a longitudinal basis. 
 
This thesis has investigated and reported the influence on PROM values of age, gender, ethnicity, 
handedness (where applicable), history of previous injury/pathology/surgery and coincident adjacent 
active joint pathology, in two different countries. No other research exists comparing electronically-
collected PROMs for multiple body regions across two continents. This research represents the only 
normative data of several PROMs investigated (11, 17, 49, 56). It also represents the largest database of 
combined normative PROM values reported in the literature (n=2360). No other study has compared 
normal scores in international cohorts or collected them remotely and electronically via the same 
research database. 
 
This thesis involved the investigation of multiple PROMs, including both subjective and combined 
subjective/objective PROMs, the latter requiring additional resources to collect. The PROMs 
investigated cover the four major joints for which the majority of literature exists (hip (13, 23), knee (10, 18), 
shoulder (12, 14, 15, 47-50) and wrist/hand PROM (11, 12)). The collected data has established a database of 
PROM values for individuals who identify themselves as asymptomatic for the body parts under 
investigation. These pooled values can be used as control cohorts for future studies investigating 
pathological cohorts.  
 
This thesis adopted carefully chosen inclusion and exclusion criteria in an effort to establish 
asymptomatic cohorts (individuals who identified themselves as ‘normal’), for the PROMs being 
investigated. Previous studies reporting the collection of “normative values” have not made attempts to 
exclude subjects with pathology to the same extent as the present study (48, 54-56, 65, 66, 72-75, 78). The 
inclusion of participants of different ages, genders and ethnicity, as well as not excluding participants 
with a history of previous non-arthroplasty surgery and coincident adjacent active joint pathology, 
represents a significant addition to the reported PROM literature. These important factors may well have 




This thesis reports that differences in age, gender, handedness (when applicable), ethnicity, history of 
injury/pathology/surgery and nationality, need to be considered when using PROMs to assess patient 
outcomes. Often, an inverse relationship is observed between age and clinical score (53, 55, 64). This 
finding is not surprising, given the age-related changes that occur over time, as well as the accumulated 
medical and surgical comorbidities that can affect a reported functional score independent of 
pathology(64). The large variation in PROM reports in individuals over the age of 80 years suggests that 
there may be other determinants of health and function that influence the subjective score reported, and 
possibly the accuracy of asymptomatic “normal” PROM values in this age older group.  
 
A detailed discussion of the individual study findings and a comparison with the current literature is 
presented in the Discussion of each manuscript Chapter.  
 
This thesis supports the conclusion that an asymptomatic “normal” control group should ideally be 
sourced from the same country of origin and be age- and gender-matched. It could include either 
subjective-only or combined subjective-objective PROM inputs without compromising the outcome data, 
depending on the investigators’ preference or available resources.  
 
Other considerations such as a history of active adjacent joint pathology or a history of inactive 
pathology in the joint under investigation, will likely have varying influence on the reported PROM value. 
The choice of a PROM that includes questions that are more joint-specific may help avoid introducing 
bias attributable to these confounders. An appreciation of the influence that coincident adjacent or 
contralateral joint pathology or a history of an inactive pathology may have on reported pathological 
PROM values will help future investigators in their interpretation of pathological patient cohorts.  
 
Certainly, when considering future studies using an electronic methodology and a pre-established 
control group, all these variables should be considered when preparing clinical publications with 
outcome data over a 2 year follow-up period. This might well enhance the accuracy of future studies 
and improve our evidence-based practice of orthopaedic surgery. 
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Limitations 
This thesis identified several limitations. One limitation is the subjective interpretation of ‘normal’ or 
‘asymptomatic’. Indeed, achieving a ‘normal’ comparative cohort relies on subjective individual reports 
of pain, movement and function. As radiographs were not performed to rule out asymptomatic, 
incidental degenerative disease, it is possible that some individuals with asymptomatic pathology were 
included in each cohort.  
 
When considering any randomly collected cohort, it is assumed that a small percentage of the general 
population will have asymptomatic, incidental undiagnosed pathology. The cohorts in this thesis are 
therefore likely representative of this natural variation in the general population.  
 
In addition, participants with a history of pathology treated by non-arthroplasty/arthrodesis surgery 
>more than 3 years ago and no longer experiencing symptoms were included. It is possible that some 
of these participants continued to suffer from some slight impairment despite their subjective perception 
that their recovery was complete and their joint was no longer considered to be a problem. When 
considering future studies, it is recommended that these patients not be removed, as the incidence of 
participants with a history of pathology treated by non-arthroplasty/arthrodesis surgery >3yrs, increases 
with increasing age. If these individuals are removed, this would introduce a selection bias; especially 
as these individuals had identified themselves as asymptomatic prior to completing their PROMs. 
 
As with any observational study, there is the potential for selection bias. Although these studies 
collected individuals randomly, no specific randomised method of recruitment was employed. The 
primary benefits of randomization are the elimination of both conscious and unconscious bias 
associated with the selection of a participant. Although individuals were approached randomly in this 
study, no specific randomization method of participant identification was employed. Another potential 
source of procedural bias was the use of electronic questionnaires, as some elderly participants may 
have declined to be involved due to the use of technology.  
 
Despite these limitations, this thesis presents a considered methodology, conceptualized in consultation 
with epidemiologists, to establish as close to ‘asymptomatic’ or ‘normal’ cohorts as practically possible 
within the constraints of ethics, budget, time, expertise and resources. The collated database will 






Several other studies have been performed in conjunction with the work completed as part of this thesis. 
Although not formally included as part of this thesis, these publications complement the present study’s 
aims and will augment planned future studies (Appendix 1 and 2).  
 
This thesis identified shoulder range of motion (ROM) as a potential variable that could be assessed 
remotely, in a similar manner to subjective-only PROMs. However, accurate measurement of shoulder 
range of motion (ROM) via a reproducible, reliable and validated electronic method had not been 
established. An electronic method has the potential for remote assessment and transfer of data. This 
thesis identified a knowledge deficiency in the assessment of shoulder ROM devices currently in use. 
The aim of the additional study was to establish the reliability and validity of different smartphone 
applications (apps) in assessing pathologic shoulder ROM and to determine whether differences in 
recorded ROM measurements affect calculated shoulder scores. It was hypothesized that there is no 
difference between shoulder ROM assessment methods and calculated shoulder scores. The study 
involved the recruitment of 75 patients with a variety of shoulder pathologies. Participants were 
assessed using a smartphone inclinometer, a smartphone virtual goniometer, a standard goniometer, 
and clinicians’ visual estimation. Shoulder strength was assessed and CSS and UCLA shoulder scores 
were calculated. The outcomes of this study are presented in Appendix 1.  
 
This thesis identified the importance of comparing a pathological patient cohort with an international, 
age- and gender-matched, asymptomatic “normal” control cohort. Investigating this knowledge 
deficiency, would help determine if an asymptomatic “normal” control group should be sourced from the 
same country of origin as the derived study. The aim of the additional study was to determine whether 
an electronic, multicenter data collection system could be used to establish normal population reference 
values for the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC). The secondary aim was to investigate 
differences in asymptomatic HOOS and WOMAC values reported in 2 geographically distinct English-
speaking countries and compare these with a symptomatic arthritic patient cohort. The study involved 
the recruitment of 552 total participants, including asymptomatic “normal” participants and end-stage, 
radiographically confirmed osteoarthritis planned for total hip arthroplasty surgery. Participants 
completed electronic HOOS and WOMAC PROMs using similar methods and analyses to those 
presented in the Chapters included in this thesis. The outcomes of this study are presented in Appendix 
2. 
 
Several studies are planned to follow-on from the research completed as part of this thesis. The Author 
is currently contributing to the Australian Orthopaedic Association National Joint Replacement Registry 
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(AOANJRR) Patient Reported Outcome Measures (PROMs) Pilot Project. The normative data 
contained in this thesis has been offered to Professor Stephen Graves as a control group for 
comparison for the AOANJRR PROMs Pilot Project.  
 
Long-term, the Author has the intention of making the data contained in this thesis available as an 
electronic control group to the AOANJRR, for use by all Australasian orthopaedic surgeons and their 
patients. The establishment of a normal de-identified control group within an electronic database will aid 
in improving the robustness and quality of future studies and assessing patient outcomes.  
 
An international database has the potential to collect de-identified data from different regions remotely 
and use this data to complement multi-centre, international clinical studies that are robust and capable 
of rapidly advancing our understanding of clinical outcomes. Overall, this will significantly enhance our 




The work described in this thesis has addressed the perceived deficiencies in the knowledge of PROM 
values in normal, asymptomatic individuals. The thesis encompasses studies of commonly employed 
validated PROMs used in the clinical assessment of conditions of the hip, knee, shoulder and wrist/hand 
PROMs. 
 
The problem areas identified, which were addressed, included (i) the establishment of asymptomatic 
population reference values for commonly used hip, knee, shoulder and wrist/hand PROMs (ii) the 
identification of factors other than pathology that influence reported PROM values and, (iii) the 
establishment of an electronic data collection system for future comparisons with pathological patient 
cohorts. 
 
To address these deficiencies, PROM data was collected electronically and remotely across two 
continents, from individuals who identified themselves as asymptomatic in the joint under question. 
Factors such as age, gender, handedness (when applicable), history of pathology, ethnicity and 
nationality, were associated with variations in reported PROM values reported. Further research has 
commenced to examine how these variables are influenced in a pathological cohort. 
 
The work described in this thesis increases the knowledge of PROM interpretation, application and 
investigation. It lies the groundwork for future studies through the establishment of a database of 2360 
asymptomatic “normal” PROM population reference values, which can be used in the establishment of 
control group(s) for comparison with pathological and surgical cohorts. It further advances the role of 
clinical follow-up in the treatment of orthopaedic conditions and our practice of evidence-based medicine. 
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APPENDIX 1  
SMARTPHONE APPLICATIONS FOR THE EVALUATION OF PATHOLOGICAL SHOULDER RANGE 
OF MOTION AND SHOULDER SCORES – A COMPARATIVE STUDY 
As published in Journal of Shoulder & Elbow Surgery. 2018; 2(1): 109-114. 
Smartphone applications for the evaluation of pathologic shoulder
range of motion and shoulder scores—a comparative study
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Keywords:






Level of evidence: Level III, Diagnostic Study
Hypothesis and background: Accurate measurement of range of motion (ROM) is important in evalu-
ating a pathologic shoulder and calculating shoulder scores. The aim of this study was to establish the
reliability and validity of different smartphone applications (apps) in assessing pathologic shoulder ROM
and to determine whether differences in recorded ROM measurements affect calculated shoulder scores.
The authors hypothesized that there is no difference between shoulder ROM assessment methods and
calculated shoulder scores.
Methods: In this nonrandomized controlled clinical trial, ROM of 75 participants with a history of shoul-
der disease (21 women, 54 men) was assessed using a smartphone inclinometer and virtual goniometer,
a standard goniometer, and clinicians’ visual estimation. Shoulder strength was assessed, and Constant-
Murley (CM) and University of California–Los Angeles (UCLA) shoulder scores were calculated.
Results: Independent of diagnosis or operation, all cases (except for passive glenohumeral abduction
of unstable shoulders) showed excellent intraclass correlation coefficients (>0.84). Interobserver relia-
bility was excellent for all ROM measures (intraclass correlation coefficient > 0.97). All modalities had
excellent agreement to values attained with the universal goniometer. There were no differences for the
calculated CM or UCLA scores between the modalities employed to measure ROM.
Conclusions: A smartphone inclinometer or virtual goniometer is comparable to other clinical methods
of measuring pathologic shoulder ROM. Clinicians can employ smartphone applications with confi-
dence to measure shoulder ROM and to calculate UCLA and CM scores. The apps are also available to
patients and may be a useful adjunct to physiotherapy, especially in cases of limited access to health care
services.
© 2017 The Authors. Published by Elsevier Inc. on behalf of American Shoulder and Elbow Surgeons.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Accurate and reliable measurement of shoulder range of motion
(ROM) is integral to the physical examination and functional eval-
uation of a pathologic shoulder. A universal goniometer (UG) is
considered the “gold standard” for measuring shoulder ROM1;
however, visual estimation is common in clinical practice as it is
more time efficient, and a goniometer is often not available.2,26,28
Other methods for measuring shoulder ROM include digital
inclinometry, digital motion capture, and high-speed cinematog-
raphy, but these require expensive, specialized equipment with
limited availability.9,10,13,16,24,28
Smartphone applications (apps) have recently been proposed as
an alternative method of measuring pathologic shoulder
ROM.15,21,22,26,29 Apps rely on an internal smartphone inclinometer26
or a photographic virtual goniometer21 to measure ROM.
Several studies have demonstrated joint ROM measured with apps
to be reliable and accurate compared with traditional
methods,7,14,15,19,21,23,25,26,29 but studies performed on the shoulder were
limited by inclusion of only participants with no joint disease (for
whom they have the most potential clinical application). In addi-
tion, no shoulder study considered the impact that ROM variability
may have on shoulder scores with an objective ROM component.
The Constant-Murley (CM) score5 and the University of California–
Los Angeles11 (UCLA) shoulder score are commonly used shoulder
assessment tools that evaluate level of function and efficacy of
The Human Research Ethics Committee, The Queen Elizabeth Hospital, Basil Heizel
Institute DX465101, approved this study: HREC/14/TQEHLMH/239.
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surgical interventions and observe clinical change over time. These
shoulder patient-reported outcome measures have the advantage
over other scoring systems of including subjective patient-derived
inputs as well as objective clinician-derived inputs, allowing a more
balanced interpretation of shoulder function.5
Shoulder scores enhance communication during the physician-
patient consultation6,8 and aid in clinical decision-making. As
shoulder ROM is an important component of these scores, mea-
surements must be accurate and reliable for the scores to be of
clinical use.
Apps have been shown to be accurate and reliable in measur-
ing ROM in normal shoulders; however, their use in the pathologic
shoulder is yet to be assessed. The authors hypothesized that smart-
phone ROM apps will provide accurate and reliable measurements
when tested on pathologic shoulders.
Materials and methods
Patients were recruited from the outpatient department of 2 ter-
tiary orthopedic units between February 2015 and February 2016.
Inclusion criteria were being English speaking, older than 18 years,
and willing to provide informed consent and having a docu-
mented current shoulder disease. Patients were excluded if they had
cognitive impairment or were unable to follow the assessor’s in-
structions. In cases of bilateral shoulder disease, both shoulders were
assessed independently and included.
One iPhone (Model 5S) was used in the study and the software
not updated during data collection. Two iPhone apps were used to
measure shoulder range of movement (ROM): GetMyROM (version
1.0.3; Interactive Medical Productions, Hampton, NH, USA), an
inclinometry-based app (Fig. 1, A); and DrGoniometer (version 1.2;
CDM S.r.L, Milano, Italy), a photo capture–based application (Fig. 1,
B). Visual ROM estimates were recorded for each subject, as were
measurements made using a standard, manual goniometer as a
control. A questionnaire recorded the subjective and functional ques-
tions of the UCLA and CM shoulder scores.
All participants were assessed with exposed shoulders. Two
medical practitioner observers with experience in musculoskel-
etal disease collected the data independently with an assistant.
Participants initially sat upright and straight on a fixed chair to sta-
bilize the spine. In this position, the following measurements were
observed: active forward flexion (Fig. 2, A), total abduction, active
glenohumeral abduction (Fig. 2, B), and passive glenohumeral ab-
duction. To assess glenohumeral joint abduction, the participants
were asked to abduct the arm while the examiner stabilized the scap-
ular. Commencement of scapula rotation was used to determine the
limit of glenohumeral joint movement.
Rotation of the shoulder was measured with participants supine
on a standard examination table. The shoulder was positioned in
90° of abduction with 90° of flexion at the elbow. With the forearm
in neutral rotation and the proximal two-thirds of the humerus sup-
ported by the table, measurements were taken for active (Fig. 2, C)
and passive external rotation and active (Fig. 2, D) and passive in-
ternal rotation. If shoulder disease prevented the participant from
abducting the shoulder to 90°, supine external rotation was mea-
sured with the elbow in contact with the side of the body (0°
abduction), and internal rotation measures were not recorded. With
all ROM tests, care was taken to avoid compensatory movements,
such as elbow extension or scapular elevation, and if these were
observed, the measurement was repeated.
Shoulder ROM was first assessed using the smartphone incli-
nometer attached to the participant with a DualFit Armband (Belkin;
Playa Vista, CA, USA). The armband was attached to the distal portion
of the humerus for seated movements, then repositioned to the wrist
for measurements performed with the participant supine. The in-
clinometer was positioned with the screen facing away from the
observer. The assistant read and recorded the ROM value with the
observer blinded to the reading. Next, the observer captured
Figure 1 The iPhone applications. (A) GetMyROM. (B) DrGoniometer.
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photographs of the participant with the shoulder positioned at the
limits of ROM, to be analyzed at a later date using DrGoniometer.
Third, the observer gave a visual estimate of shoulder ROM and last
measured the ROM using the standard goniometer.
A myometer (Isometer; Innovative Design Orthopaedics Ltd.,
London, UK) was employed to measure shoulder strength using the
method described by Constant et al.5 Participants stood with their
feet shoulder-width apart and the arm held at 90° of abduction in
the scapular plane. The forearm was placed in full pronation and
shoulder internal rotation. A looped arm strap was placed 2 cm prox-
imal to the wrist. With the elbow straight at all times, participants
were instructed to lift up with maximal strength. The measure-
ment was repeated 2 more times and the highest value used to
calculate the CM score.5,29 Participants who were not able to es-
tablish the desired degrees of abduction or experienced pain when
completing this part of the assessment were assigned a strength
score of 0 and were not subjected to further strength measure-
ment. Strength measurements were used in conjunction with the
questionnaires to calculate the UCLA and CM shoulder scores.
To assess the reliability of the 4 methods, all measurements were
completed by 2 independent observers. An intraclass correlation co-
efficient (ICC) was calculated using SAS 9.3 (SAS Institute, Cary, NC,
USA). An ICC was calculated for each ROM test, interpreted as follows:
0.00-0.40, poor correlation; 0.41-0.59, fair correlation; 0.60-0.74,
good correlation; and 0.75-1.00, excellent correlation.4
A Bland-Altman analysis was used to assess the level of agree-
ment between the ROM measurement modalities. A 95% limit of
agreement was defined as ±1.96 standard deviations around the
mean difference from measurements obtained by the UG, thus pro-
ducing a lower and upper level of agreement.
A negative binomial generalized estimating equation was used
to account for clustering on random effects of the subjects and raters.
Assumptions of linear regression were not upheld. Modeling was
performed for the CM scores and ROM as well as for UCLA scores
and ROM.
Results
From February 2015 to February 2016, 75 patients were re-
cruited from the outpatient department of 2 tertiary orthopedic units
(21 women, 54 men). The average age was 46 years (range, 24-94
years). Fourteen patients had bilateral shoulder disease.
The underlying shoulder diseases in descending order of fre-
quency included shoulder instability (n = 23), degenerative changes/
Figure 2 Measurements of (A) forward flexion, (B) glenohumeral abduction, (C) external rotation, and (D) internal rotation.
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arthritis (n = 9), inflammation (n = 9), prior fracture (n = 4), and soft
tissue disease (n = 30). Diagnoses and surgical interventions are pre-
sented in Table I.
In all cases for the group diagnoses (except for passive gleno-
humeral abduction of the instability group), ICC values were classified
as having excellent agreement (>0.84). In regard to surgical inter-
vention, the ICC value for each ROM test was >0.95.
The ICC values are presented in Table II. All values were >0.97,
indicating excellent agreement between the 4 methods of
measurement for each ROM. Each ROM variable showed a left-
skewed distribution.
The results of Bland-Altman plots, comparing the other 3 methods
of measurement with the measurements obtained by the UG, are
presented in Table III. These values are within a narrow range and
indicate generally superior agreement, although active and passive
glenohumeral abduction had the narrowest limit range (ie, more
agreement between the methods of measurement and UG), and
forward flexion resulted in a larger range of values.
Nineteen participants (25.3%) were not able to complete strength
assessments as a result of pain (n = 15) or loss of ROM (n = 4). These
participants were assigned a strength score of 0 in calculating UCLA
and CM scores. When the CM and UCLA scores were calculated for
each method of assessing ROM, all methods revealed identical mean
CM scores (74; range, 6-100) and mean UCLA scores (29; range,
7-35).
Discussion
This study demonstrated that the ROM measurements in patho-
logic shoulders are consistent in comparing a UG with visual
estimates and 2 different smartphone ROM apps. It also demon-
strated that there is no difference in the calculated shoulder UCLA
and CM scores using the 4 different methods, suggesting that newer
technologies that use smartphone applications may be a useful tool
in the clinical setting.
Previous studies3,12,17,30 have assessed the accuracy and validity
of smartphone apps in measuring joint ROM; however, those focused
on the shoulder were limited by assessing only normal shoulders
in healthy, young individuals.15,18,21 In contrast, this study assessed
patients of varying ages with a spectrum of shoulder diseases, thus
providing a relevant clinical context and a broader spectrum of as-
sessable shoulder ranges over which to compare the assessment
modalities. Previous studies were also limited to the assessment of
active shoulder motion only.15,18,21 In addition to examining both
active and passive ROM, this study also assessed a more complete
set of shoulder movements, including internal and external rota-
tion, abduction, and forward flexion. This study also assessed the
Table I
Diagnoses and operations of participants (N = 75)
Diagnosis Operation
Inflammation (n = 9)
SA bursitis ± impingement
Scapulothoracic bursitis/snapping
scapula
Fractures (n = 4)
Proximal humerus
Clavicle





Instability (n = 23)
Traumatic (including dislocations)
ACJ dislocation/subluxation
Soft tissue (n = 30)




No operation (n = 58)







ACJ lateral clavicle excision
Rotator cuff repair
Open washout of shoulder joint
Total shoulder arthroplasty (n = 1)
Reverse
SA, subacromial; ACJ, acromioclavicular joint; SCJ, sternoclavicular joint; GHJ, gle-
nohumeral joint; SLAP, superior labral tear from anterior to posterior.
Table II
Interobserver reliability for each range of motion (ROM) measurement method




Forward flexion Clinician 1.00 0.99 1.00
Goniometer 0.99 0.99 1.00
GetMyROM 0.99 0.98 0.99
DrGoniometer 1.00 0.99 1.00
Total active abduction Clinician 1.00 0.99 1.00
Goniometer 0.99 0.99 1.00
GetMyROM 0.99 0.99 1.00
DrGoniometer 0.99 0.99 1.00
Active glenohumeral
abduction
Clinician 0.99 0.99 1.00
Goniometer 0.98 0.97 0.99
GetMyROM 0.98 0.97 0.99
DrGoniometer 0.98 0.97 0.99
Passive glenohumeral
abduction
Clinician 0.99 0.99 1.00
Goniometer 0.98 0.99 0.99
GetMyROM 0.97 0.95 0.99
DrGoniometer 0.98 0.96 0.99
Active internal rotation Clinician 0.99 0.99 0.99
Goniometer 0.99 0.99 0.99
GetMyROM 0.98 0.97 0.99
DrGoniometer 0.99 0.99 1.00
Passive internal rotation Clinician 0.99 0.98 0.99
Goniometer 0.99 0.99 0.99
GetMyROM 0.98 0.96 0.98
DrGoniometer 1.00 0.99 1.00
Active external rotation Clinician 0.99 0.98 0.99
Goniometer 0.99 0.98 0.99
GetMyROM 0.99 0.98 0.99
DrGoniometer 1.00 0.99 1.00
Passive external rotation Clinician 0.99 0.99 1.00
Goniometer 1.00 0.99 1.00
GetMyROM 0.99 0.98 0.99
DrGoniometer 0.99 0.99 1.00
ICC, intraclass correlation coefficient.
Table III
















Forward flexion Clinician 1.69 −5.17 8.55
GetMyROM −0.76 −9.64 8.11
DrGoniometer −0.56 −9.63 8.52
Total active abduction Clinician 0.37 −6.46 7.20
GetMyROM 0.47 −7.87 8.81
DrGoniometer 0.81 −7.73 9.35
Active glenohumeral
abduction
Clinician −0.18 −2.90 2.54
GetMyROM −0.19 −4.71 4.32
DrGoniometer −0.41 −6.93 6.12
Passive glenohumeral
abduction
Clinician −0.07 −2.04 1.90
GetMyROM −0.38 −4.02 3.25
DrGoniometer −0.01 −2.32 2.30
Active internal rotation Clinician −0.29 −5.51 4.93
GetMyROM 0.51 −7.11 8.14
DrGoniometer −1.29 −10.00 7.43
Passive internal rotation Clinician 0.00 −4.66 4.66
GetMyROM 0.55 −5.04 6.13
DrGoniometer −1.41 −9.83 7.01
Active external rotation Clinician 0.01 −5.02 5.05
GetMyROM −0.08 −8.32 8.17
DrGoniometer 0.20 −8.23 8.63
Passive external rotation Clinician 0.42 −5.18 6.02
GetMyROM 0.40 −7.58 8.37
DrGoniometer 0.13 −7.65 7.91
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clinically relevant movement of glenohumeral joint abduction, an
important sign that can assist in differentiating subacromial and sub-
deltoid adhesions from adhesive capsulitis in pathologic and
postoperative patients. To the authors’ knowledge, this movement
has not previously been investigated using different ROM assess-
ment modalities.
This study is the first to compare 4 different shoulder ROM as-
sessment tools in a pathologic patient cohort. The 4 assessment
modalities used (the clinician’s visual estimation, inclinometer-
based smartphone application [GetMyROM], photograph-based
[DrGoniometer] smartphone application, and UG) demonstrated ex-
cellent agreement. This finding was similar to that of Werner et al,
who assessed postsurgical shoulder ROM in patients having un-
dergone total shoulder replacement surgery and reported excellent
correlation when using an inclinometer Smartphone application in
isolation.29 This study is also one of the few studies that assessed
an older population cohort (mean age, 46 years), in various planes
of shoulder movement, with various shoulder diseases and diag-
noses. The only other study to examine inclinometer- and
photograph-based shoulder assessment tools relied exclusively on
measurements of external rotation performed on young, healthy sub-
jects (mean age, 26.4 ± 7.6 years).21
Certain advantages exist in adopting these new technologies.
Inclinometry-based applications allow fast, reliable measure-
ments of shoulder ROM and are widely available and cost-effective,
given the prevalence of smartphone ownership in the general pop-
ulation. They are available not only to physicians but also to allied
health professionals and patients. As well as being used in a clin-
ical setting, the inclinometry-based apps allow patient
self-measurement,12 providing real-time feedback for exercise com-
pleted at home. This may be of particular benefit to those with
limited access to health care because of rural location or disabili-
ty, for whom some assessment may be performed by a combination
of telephone, tele-link, or secured e-mail.
Photograph-based applications, whereby clinicians make mea-
surements in a delayed fashion (post-production and independent
of the patient’s location), allow images to be printed and filed in
patient notes for comparison during subsequent visits. Like
inclinometry-based apps, photograph-based applications allow ac-
curate ROM assessment when a goniometer is not available or when
a face-to-face interaction with a health professional is not imme-
diately available. Moreover, the physician-patient interaction can
potentially be enhanced by demonstrating the patient’s progress in
ROM over time.12,20
Whereas visual assessment of ROM may require experience to
give an accurate estimation, a recent study29 reported that the skill
level of medical assessor does not influence the ROM assessment
with use of smartphone applications (ie, student vs. medical clini-
cian). This is important, as clinicians and allied health practitioners
who do not have exclusively musculoskeletal practices may employ
these smartphone applications with the confidence that they will
produce consistent results. Non–musculoskeletal-focused clini-
cians are less likely to have experience with visual estimation of
shoulder ROM, and consequently the measurements obtained may
be affected.
The UCLA and CM scores are important adjuncts to the man-
agement of patients with shoulder disease and can be used to assess
for change in function over time. Both have subjective and objec-
tive components that allow a more balanced interpretation of a
patient’s true shoulder function. This is the first study to compare
smartphone applications for measuring shoulder ROM in a patho-
logic patient cohort and subsequently using these measurements
to calculate and to compare UCLA and CM shoulder scores. In this
study, both the UCLA and CM shoulder scores were similar in com-
paring various modalities of ROM measurement. These findings
suggest that these smartphone applications can be used with con-
fidence to calculate UCLA and CM shoulder scores in patients with
a spectrum of shoulder diseases.
Limitations exist in using inclinometer- and photograph-based
smartphone applications for shoulder ROM measurement. Incli-
nometer applications require the mobile device to be in contact with
the patient. This is best achieved with an instrument that physi-
cally holds the phone to the patient (such as an armband).26 Hygiene
issues may be raised when an armband is used repeatedly and
suggest the need for disposable armbands.1,27 The position of the
measurement device is important to achieve consistent results. It
was our experience that the armband sometimes required adjust-
ment (eg, rotated around the longitudinal axis of the humerus) to
attain the appropriate measure. Vigilance of the assessor was re-
quired to adjust the armband if it slipped or loosened after initial
application.
Photograph-based smartphone applications had similar consid-
erations, especially when the examiner was taking the picture and
in positioning the virtual goniometer on anatomic landmarks to
measure the angles under investigation.12 Errors could be made if
the picture was taken short of maximal ROM or if the photograph
was mistimed (and not picked up). Care needed to be taken in mea-
suring the angles under investigation in the photographs, especially
in placing markers on the desired anatomic landmarks.
There are limitations to this study. The 2 observers were highly
trained and had many years of experience in shoulder examina-
tion. This may have influenced the visual estimation results, which
may not be reproducible for clinicians with less experience. Care
should be taken in interpreting this result, as visual estimation re-
quires a certain level of expertise and practice, which may take
several years to achieve. This modality has the most inherent vari-
ability and is not recommended for routine use (especially for
clinicians who have not self-evaluated their assessments). Ongoing
self-evaluation is required to confirm that this technique is valid
for each clinician.
Another limitation was the sample size, which was not random-
ized and was composed of more men than women. The average age
of the sample was skewed to the elderly (likely representative of
the larger proportion of disease found in the older age groups). A
broader and larger sample would allow a more in-depth analysis
by gender and age subsets. Future studies could incorporate exam-
ination of dynamic movements in addition to static assessments.
Conclusion
Technologic advances offer the opportunity to adopt new tools
that can improve patient assessments and follow-up and ultimate-
ly lead to improved clinical outcomes. Smartphone app use is a
widely available, cost-effective method to assist clinicians in accu-
rately measuring joint range of movement, including that of the
shoulder, knee, spine, elbow, and ankle.3,12,17,30 This study demon-
strates that shoulder ROM can be reproducibly measured using 4
independent methods. Smartphones can be used with confidence
by clinicians to provide a reliable, reproducible, practical, and in-
expensive way of assessing shoulder ROM.
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The number of total hip arthroplas-ties (THAs) performed continues to increase.1 Currently, most clini- cal research and joint registry outcome data involve observation of THA failure and revision rates. Patient-reported out-
come measures (PROMs) allow for the 
evaluation of THA outcomes prior to 
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The primary aim of this study was to determine whether an electronic, multi-
center data collection system could be used to establish normal population ref-
erence values for the Hip Disability and Osteoarthritis Outcome Score (HOOS) 
and the Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC). The secondary aim was to investigate differences in asymptomatic 
HOOS and WOMAC values reported in 2 geographically distinct English-speak-
ing countries and compare these with a symptomatic arthritic patient cohort. A 
total of 552 participants were recruited. Asymptomatic Australian and Canadian 
cohorts were compared; combined asymptomatic cohorts were compared with 
an arthritic cohort. There was a statistically significant association between age 
and asymptomatic HOOS (P<.0001) and WOMAC (P<.0001) values; as age 
increased, values worsened. Females had worse HOOS and WOMAC values 
(P<.0001). When compared with age- and sex-matched asymptomatic partici-
pants, arthritic participants had worse scores (P<.0001). Asymptomatic Austra-
lians had a statistically significant 3.8% better (higher) HOOS (P<.0001) in all 
age groups (P<.0001). When compared with age- and sex-matched asymptom-
atic participants, younger arthritic participants reported worse activities of daily 
living and sports and recreation HOOS values. This observational study estab-
lished an electronic HOOS and WOMAC patient-reported outcome measures 
database of asymptomatic individuals in 2 geographically distinct countries. 
An asymptomatic control group should be sourced from the same country of 
origin as the proposed study. Factors that should be considered when recording 
the HOOS and WOMAC include age, sex, geographic location, history of an 
inactive hip problem, contralateral hip disease, and active knee, ankle, or foot 
problems. [Orthopedics. 201x; xx(x):xx-xx.]
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failure and revision. Patient-reported out-
come measures have indicated that 15% 
of patients undergoing elective THA are 
not satisfied with their results.2 These data 
are not routinely collected by most THA 
registries. Patient-reported outcome mea-
sures can provide surgeons and research-
ers with valuable long-term data on the se-
verity of and change in symptoms before 
and after THA.
Approximately 20 different hip PROM 
scoring systems have been described.3,4 
The PROMs working group of the Inter-
national Society of Arthroplasty Regis-
tries reported that the Hip Disability and 
Osteoarthritis Outcome Score (HOOS) 
and the Western Ontario and McMaster 
Universities Osteoarthritis Index (WOM-
AC) are the PROMs most commonly 
used for THA registries.5 The HOOS is 
a PROM used to measure subjective hip 
function and symptoms in adult patients 
with hip disability.6,7 This includes indi-
viduals with or without hip osteoarthritis. 
The HOOS has the complete and original 
WOMAC within it.
The HOOS and the WOMAC can be 
administered quickly, requiring approxi-
mately 10 to 15 minutes for patients to 
complete. Swedish, Dutch, and French 
versions have been previously validated.6,8 
The Swedish and French versions of the 
HOOS have shown high responsiveness 
(ie, the ability to detect clinical change) 
before and after THA in patients with hip 
osteoarthritis.4,7
The HOOS and the WOMAC incor-
porate subjective reports of patients’ hip 
and associated problems. Several investi-
gators have reported an inverse relation-
ship between age and PROM scores in as-
ymptomatic populations, suggesting that 
as age increases, the reported “normal” 
PROM score decreases.9 It is possible that 
a similar inverse relationship exists for the 
HOOS and the WOMAC; however, to the 
authors’ knowledge, this has not been re-
ported.
Despite their widespread use since 
their description in 1988 and 2003, no 
study has investigated the effect of admin-
istering an English version of the HOOS 
or the WOMAC to asymptomatic individ-
uals and to individuals with symptomatic 
end-stage hip osteoarthritis planned for 
THA.6,10 The primary aim of this study 
was to determine whether an electronic, 
multicenter data collection system could 
be used to establish normal, asymptom-
atic, population reference values for the 
HOOS and the WOMAC and to investi-
gate potential regional differences in the 
reported values by assessing 2 geographi-
cally distinct English-speaking countries 
(Australia and Canada). The secondary 
aim was to compare this asymptomatic 
HOOS and WOMAC cohort with a symp-
tomatic patient cohort with end-stage hip 
osteoarthritis planned for THA. The au-
thors hypothesized that longitudinal data 
from symptomatic arthritic populations 
should be compared with data from age- 
and sex-matched control cohorts sourced 
from the same country of origin as the 
study (ie, local cohorts should only be 
compared with a local control group).
Materials and Methods
Independent ethics board approval was 
granted from each institution involved in 
this study. Adult participants were recruit-
ed from November 2014 to January 2017. 
Participants for the asymptomatic cohort 
were recruited from medical outpatient 
departments, driver’s licensing offices, 
and community centers. There were no 
incentives or payment for participation. 
Informed consent was obtained from all 
individuals included in the study.
An asymptomatic cohort was estab-
lished by approaching adult Australian 
and Canadian participants who identified 
themselves as having no symptoms of 
problems in either hip. Inclusion criteria 
were no self-reported pain or pathology in 
either hip and fluent in English. No medi-
cal notes or radiographs were reviewed for 
these individuals. Exclusion criteria were 
cognitive impairment, a history of inflam-
matory or hip arthritis, significant lumbar 
spine problems that interfered with func-
tion, active hip pathology, previous hip 
arthroplasty, or any hip surgery within 
the past 3 years. A history of inactive (ie, 
asymptomatic) hip pathology, including 
previous surgery more than 3 years ear-
lier, was recorded. Reports of concurrent 
knee or ankle pathology or pain affecting 
function were recorded.
A consecutive sample of English-
speaking patients with end-stage, ra-
diographically confirmed osteoarthritis 
planned for THA were recruited from a 
single tertiary referral center. Exclusion 
criteria were cognitive impairment and 
significant lumbar spine problems inter-
fering with function. A history of active 
knee or ankle pathology or pain affecting 
function, as well as a history of contralat-
eral THA or hip problems, was recorded.
A total of 552 participants were re-
cruited (496 asymptomatic and 56 symp-
tomatic arthritic), with 273 being women 
and 279 being men. They were divided 
into 5 age subgroups: 40-49, 50-59, 60-
69, 70-79, and 80 years and older.
Participants self-administered the 
HOOS (English version LK 2.0), which 
consisted of 40 items assessing 5 catego-
ries of PROMs: symptoms and stiffness (5 
questions); pain (10 questions); function 
and daily living (17 questions); function, 
sports, and recreational activities (4 ques-
tions); and quality of life (4 questions). 
Participants were directed to answer each 
item by selecting 1 of 5 descriptive re-
sponses presented as a Likert scale. Each 
question was scored from 0 to 4, yielding 
a total score ranging from 0 (severe dis-
ability) to 100 (no disability).
The HOOS contained all WOMAC LK 
3.0 questions in their original, unchanged 
form. The WOMAC scores were calcu-
lated as described by Nilsdotter et al8 and 
included subscales for pain, stiffness, and 
function. All items were scored from 0 
to 4, and scores for each of the subscales 
were calculated from the sum of the in-
cluded items. A normalized score up to 
100 was calculated for each subscale, with 
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0 indicating maximal problems and symp-
toms and 100 indicating no problems. A 
total WOMAC score of 0 to 100 was cal-
culated for each participant, with a higher 
score indicating worse pain, stiffness, and 
function.
Chi-square and Fisher’s exact tests were 
used for the analysis of differences between 
arthritic and asymptomatic cohorts. Ordi-
nal logistic models were used for the analy-
sis of differences in HOOS and WOMAC 
values because these scores are ordinal (ie, 
lower scores correlate with worse symp-
toms for HOOS, and higher scores corre-
late with worse symptoms for WOMAC). 
Poisson regression models were used to 
assess for associations between 5 HOOS 
and 4 WOMAC subscales and predictors 
such as country, age, and sex. SAS version 
9.4 statistical software (SAS Institute Inc, 
Cary, North Carolina) was used.
results
The demographics of each cohort are 
presented in Table 1. The HOOS values 
and statistical analyses are presented in 
Table 2 and Figure 1. On adjustment for 
sex, asymptomatic Canadian participants 
had worse (lower) HOOS values across 
all age groups (P<.0001) compared with 
asymptomatic Australian participants. 
Arthritic participants had worse (lower) 
HOOS values than age- and sex-matched 
asymptomatic participants (P<.0001). 
Female participants had worse (lower) 
HOOS values than age-matched partici-
pants (P<.0001).
The HOOS subscale values and uni-
variate Poisson regressions are presented 
in Table 3. Asymptomatic Australian par-
ticipants had a HOOS for pain that was 
2.1% better (higher) than that of age- and 
sex-matched asymptomatic Canadian 
participants (P=.0123; 95% confidence 
interval, 1.0044-1.0369). Asymptom-
atic Australian participants also had bet-
ter (higher) HOOS subscale values for 
symptoms (P=.0003), activities of daily 
living (P=.0006), sports and recreation 
(P<.0001), and quality of life (P<.0001). 
Overall, asymptomatic Australian partici-
pants had a total HOOS value that was 
3.8% better (higher) than that of age- and 
sex-matched asymptomatic Canadian par-
ticipants (P<.0001).
The WOMAC scores and statistical 
analyses are presented in Table 4 and 
Figure 2. On adjustment for sex, when 
compared with asymptomatic Australian 
participants, asymptomatic Canadian par-
ticipants had worse (higher) WOMAC 
scores in the 70 to 79 years (P=.0025) and 
80 years and older (P<.0001) age groups 
only. No difference in HOOS value was 
reported for asymptomatic participants 
younger than 70 years (P>.05). Arthritic 
participants had worse (higher) WOMAC 
scores than age- and sex-matched asymp-
tomatic participants (P<.0001). Female 
participants had worse (higher) WOMAC 
scores compared with age-matched par-
ticipants (P<.0001).
The WOMAC subscale scores and uni-
variate Poisson regressions are presented 
in Table 5. Asymptomatic Australian par-
ticipants had a better (lower) WOMAC 
score on all subscales compared with age- 
and sex-matched asymptomatic Canadian 
participants (P<.0001). Overall, asymp-
tomatic Australian participants had a total 
WOMAC score that was 2.5% lower than 
that of age- and sex-matched asymptom-
atic Canadian participants (P<.0001).
discussion
The HOOS and the WOMAC are 
PROMs that provide valuable informa-
tion for surgeons and researchers assessing 
and quantifying outcomes before and after 
THA. This study assessed the HOOS and 
the WOMAC PROMs in asymptomatic 
and pathological, arthritic cohorts. Com-
paring both asymptomatic and arthritic hip 
cohorts enables a more accurate interpreta-
tion of the normal, age-related functional 
changes that will affect THA patients being 
followed on a longitudinal basis.
Establishment of a PROM reference 
database for asymptomatic individuals 
will aid in the interpretation of THA pa-
tients’ PROM reports on a longitudinal 
basis. An electronic database allows re-
mote administration, thereby minimizing 
resources, cost, and personnel required to 
collect, collate, and process data.11 This 
theoretical advantage is enabled by the 
HOOS and the WOMAC PROMs contain-
ing only subjective responses and not re-
quiring a face-to-face interaction with an 
assessor. These PROMs have the potential 
for remote access by both researchers and 
patients, who can complete questionnaires 
when convenient and have electronic re-
minders set. An electronic database also 
permits simultaneous data entry and data 
analyses, allows automated participant re-
minders or response time points, and has 
the potential to link to an electronic medi-
cal record. This could increase the re-
sponse rate, which can be low with mailed 
paper questionnaires.
In this study, females in both the as-
ymptomatic and the arthritic cohorts had 
worse HOOS and WOMAC values. This 
finding is similar to that of other stud-
ies.12,13
An inverse correlation was found be-
tween age and reported PROMs in asymp-
tomatic participants (ie, as age increased, 
the reported PROM score was worse). 
This finding was not surprising given the 
age-related changes that occur with time 
and the accumulated medical and surgical 
comorbidities that can affect lower limb 
function and the resultant reported PROM 
score. Certainly, as patient age increases, 
perfect PROMs should not be expected.
Asymptomatic individuals 70 years 
and older showed great variation in report-
ed HOOS and WOMAC values, with Ca-
nadian participants having worse PROM 
values than with their Australian counter-
parts. This trend was well demonstrated 
on comparison of each PROM graph, with 
national asymptomatic PROMs becom-
ing more divergent in individuals 70 years 
and older. In contrast to the HOOS, which 
showed statistical differences between all 
age groups for all subscales, the WOMAC 
did not show statistically significant dif-
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ferences for all subscales. The WOMAC 
did show a significant difference for in-
dividuals 70 years and older, but not for 
younger individuals. This observation 
may be explained by an increased rel-
evance of these particular subscale ques-
tions to younger and more high-demand 
individuals, as the HOOS was developed 
as an expansion of the WOMAC (with the 
inclusion of questions relating to sports 
and recreation and decreased quality of 
life). Therefore, the authors recommend 
that the HOOS be used in preference to 
the WOMAC to detect differences be-
tween cohorts in the younger age groups 
(40 to 69 years).
Arthritic participants reported statisti-
cally worse PROMs compared with their 
age- and sex-matched asymptomatic coun-
terparts. This finding was not surprising 
given the end-stage arthritic changes that 
defined this cohort and the effect that this 
had on their lower limb function. Interest-
ingly, in contrast to the asymptomatic co-
hort, in this study a correlation was found 
between age and reported PROM in the ar-
thritic cohort (ie, as age increased, PROM 
score improved). The authors postulate 
that the apparent age-related improvement 
in PROMs was unlikely to be related to the 
Table 2
Hip Disability and Osteoarthritis Outcome Scoresa
Asymptomatic Cohort, Mean HOOS P






















Male 97.28 92.52 94.90 29.68 87.19 .0002 <.0001 <.0001
Female 95.95 90.86 93.39 23.84 87.53 <.0001 <.0001 <.0001
Age group
40-49 y 98.78 94.98 96.84 4.88 93.08 .0383 <.0001 <.0001
50-59 y 97.88 94.47 96.15 19.63 92.18 .0271 <.0001 <.0001
60-69 y 94.63 91.09 92.88 24.45 84.75 .0243 <.0001 <.0001
70-79 y 94.69 88.25 91.29 34.96 80.81 .0039 <.0001 <.0001
80+ y 96.77 77.45 88.49 34.08 78.37 <.0001 <.0001 <.0001
Overall 96.62 91.68 94.14 27.29 87.36 <.0001 <.0001 .0001
Abbreviation: HOOS, Hip Disability and Osteoarthritis Outcome Score. 
aMaximum score of 100 points, with a lower score indicating worse pain, stiffness, and functional limitation.
Figure 1: Scattergram showing Hip Disability and Osteoarthritis Outcome Score for each age group among 
asymptomatic Australian participants (blue), asymptomatic Canadian participants (red), and arthritic co-
hort (green). Higher scores indicate better outcomes for symptoms, pain, function, and quality of life. 
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natural history of osteoarthritis, but rather 
to the threshold of operative intervention 
for individuals with radiographically con-
firmed osteoarthritis. Because, by defini-
tion, all of the arthritic participants were 
indicated and planned for surgery, younger 
individuals in this cohort required worse 
symptoms and greater impact on function 
before reaching the threshold for consider-
ation for THA intervention. Older arthritic 
individuals likely had a lower threshold 
indication for THA, given the lower im-
plant demands and lower risk of revision 
surgery in these age groups.1
Younger arthritic participants were 
also more likely to report worse activities 
of daily living and sports and recreation 
HOOS values than their asymptomatic 
age-matched counterparts. This study also 
found that as age increased, the disparity 
between scores in all cohorts diminished, 
particularly the subscales (ie, as age in-
creases, asymptomatic and symptomatic 
PROM values approach one another). 
This observation highlights the implica-
tions of osteoarthritis in younger arthritic 
individuals, which likely translate to a 
greater impact on occupation, livelihood, 
and recreation. Future longitudinal stud-
ies should assess the impact of THA on 
reported PROMs in younger individuals 
compared with the more common elderly 
THA patients.
Factors other than age were also found 
to be associated with differences in PROM 
values. Participants who reported a histo-
ry of an inactive (previous) hip problem or 
an active knee, ankle, or foot problem had 
worse PROM scores. The asymptomatic 
Canadian cohort reported a higher inci-
Table 3
Univariate Poisson Regressions of Hip Disability and 
Osteoarthritis Outcome Score Subscale Scores
Asymptomatic Cohort,  Mean Score
HOOS Subscale Australian Canadian
95% Confidence 
Interval P
Pain 97.67 95.71 1.0044-1.0369 .0123
Symptoms 97.23 94.44 1.0133-1.0462 .0003
Activities of daily 
living
97.93 95.24 1.0120-1.0447 .0006
Sports and recre-
ation
94.74 87.40 1.0664-1.1019 <.0001
Quality of life 96.25 92.63 1.0225-1.0559 <.0001
Total score 483.83 465.41 1.0321-1.0470 <.0001
Abbreviation: HOOS, Hip Disability and Osteoarthritis Outcome Score. 
Table 4
Western Ontario and McMaster Universities Osteoarthritis Index Scoresa 
Asymptomatic Cohort, Mean Score P



















Male 1.79 4.97 3.36 61.79 10.32 .0018 <.0001 <.0001
Female 2.80 6.38 4.60 68.43 9.98 .0004 <.0001 <.0001
Age group
40-49 y 0.96 3.25 2.13 80.60 5.72 .1237 <.0001 <.0001
50-59 y 1.47 3.42 2.44 70.25 6.01 .1231 <.0001 <.0001
60-69 y 3.65 5.86 4.74 65.32 11.94 .0830 <.0001 <.0001
70-79 y 3.36 8.84 6.26 57.63 15.81 .0025 <.0001 <.0001
80+ y 2.10 16.67 8.34 60.63 18.07 <.0001 <.0001 <.0001
Overall 2.30 5.69 3.99 64.52 10.15 <.0001 <.0001 .0001
aA total of 24 items with a possible maximum score of 96. The final score is expressed in a percentage and calculated by dividing an individual’s 
score by the total score and multiplying that by 100, thereby making a normalized maximum 100-point score. A higher score indicates worse pain, 
stiffness, and functional limitation.
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dence of inactive hip problems, as well as 
more active knee, ankle, or foot problems. 
This may also have influenced the PROM 
values reported, as both of these variables 
were associated with worse PROM scores 
in the combined asymptomatic cohorts, 
independent of age.
There is significant overlap in the 
functional questions contained in the as-
sessment tools, suggesting that these 
functional tools may not represent hip-
specific PROMs and may fail to discrimi-
nate a primarily hip source of pathology 
from other sources of lower limb incapac-
ity. This should be considered when us-
ing these tools for patients with multiple, 
concurrent lower limb pathologies. To the 
authors’ knowledge, few (if any) studies 
investigating either asymptomatic or ar-
thritic cohorts have considered the effect 
these variables may have on the reported 
HOOS and WOMAC values. In addition, 
most studies do not record the incidence 
of contralateral hip disease (either active 
or inactive), concurrent spinal disease, or 
active bilateral or unilateral knee, ankle, 
or foot pathology. Rarely is a history of 
contralateral hip disease or THA reported 
in arthritic or THA patient cohorts.8,14-16
In this study, efforts were made beyond 
those reported previously to establish an 
asymptomatic control group that fulfilled 
the criteria of being a control group. Ex-
clusion criteria were carefully chosen to 
minimize the inclusion of participants 
with active pathology and to collect an 
asymptomatic population who identified 
themselves as having normal hips. To the 
authors’ knowledge, this study represents 
the largest database of normal HOOS and 
WOMAC values reported in the literature. 
Although other researchers have recorded 
normal values for other musculoskel-
etal assessment tools, most have collected 
fewer than 150 participants17 or have stud-
ied only young, active individuals18 or in-
dividuals not first screened for active joint 
pathology.13
Several studies have indicated that a 
perfect hip score may not be reported in 
an asymptomatic or disease-free popula-
tion.13,19 In a representative sample, it is 
assumed that a certain percentage of the 
general population will have asymptom-
atic, incidental hip pathology. A repre-
sentative control cohort without active pa-
thology would include a small percentage 
of participants with the following: a his-
tory of inactive hip pathology; a history of 
previous successful non-arthroplasty hip 
surgery; incidental subclinical hip pathol-
ogy; and incidental clinical hip pathology 
(undiagnosed or not investigated). In this 
study, all efforts within the constraints of 
ethics approval, budget, and practical par-
ticipant selection were made to exclude 
patients with active hip pathology from 
the asymptomatic cohort. Many previous 
Figure 2: Scattergram showing Western Ontario and McMaster Universities Osteoarthritis Index score for 
each age group among asymptomatic Australian participants (blue), asymptomatic Canadian participants 
(red), and arthritic cohort (green). Higher scores indicate worse pain, stiffness, and function.
Table 5
Univariate Poisson Regressions of Western Ontario and 
McMaster Universities Osteoarthritis Index Subscale Scores





Pain 0.39 0.76 0.42-0.52 <.0001
Stiffness 0.24 0.53 0.35-0.45 <.0001
Function 1.43 3.34 0.38-0.43 <.0001
Total score 2.07 4.63 0.41-0.45 <.0001
Abbreviation: WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index. 
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studies investigating normal reference 
values did not attempt to exclude these 
participants from their sample cohorts.13 
Thus, in these studies, the numbers of 
responders with active hip pathology or 
a history of hip pathology are unknown. 
The authors recommend that future stud-
ies consider these variables when estab-
lishing a control group against which to 
compare an interventional group using the 
HOOS and WOMAC PROMs.
This study reported differences be-
tween 2 geographically distinct asymp-
tomatic cohorts from 2 English-speaking 
Western countries. Although this study 
represents the largest cohort of asymp-
tomatic hip PROM scores reported in the 
literature, this finding may reflect a true 
difference between the population cohorts 
or a selection or reporting bias. Cultural 
and societal differences may also explain 
the disparity in scores. Although the dis-
tribution of ethnicity was not explored in 
this study, the 2 countries have Western-
ized societies and similar distributions 
based on reports from the Australian Bu-
reau of Statistics20 and Statistics Canada.21 
Future studies with larger samples may be 
able to assess these reported differences. 
On the basis of their findings, the authors 
recommend that future studies using the 
HOOS and the WOMAC be performed 
with comparisons made against a control 
group sourced from the same country of 
origin.
The current study had important limita-
tions that should be considered when in-
terpreting the results. The arthritic cohort 
represented a sample of consecutive pa-
tients with end-stage osteoarthritis planned 
for THA. In contrast, the asymptomatic 
cohort was collected randomly, with no 
specific randomization method regarding 
participant identification being employed. 
Because no radiographs were obtained to 
confirm whether participants had asymp-
tomatic degenerative hip disease, it is pos-
sible that some of these individuals were 
included in the cohorts even though they 
self-reported as asymptomatic.
As with any observational study, there 
is the potential for selection bias, particu-
larly when there is no randomization. The 
primary benefit of randomization is the 
elimination of both conscious and uncon-
scious bias associated with the selection 
of a participant. Randomization was not 
employed in this study secondary to time, 
resource, and cost constraints.
Another potential source of selection 
bias involves the use of electronic ques-
tionnaires. Patients with severe wrist and 
hand pathology may be less able to com-
plete electronic questionnaires using com-
puters or tablets. The technology also as-
sumes that the patient is capable of being 
and willing to be an active participant and 
that the patient prefers a virtual method of 
follow-up over a face-to-face clinician–pa-
tient interaction. This may not be the case 
for the entire population and especially 
for the elderly, who may not be computer 
savvy.22 Participants may have declined in-
volvement because of the technology. In-
terviewer bias may have been introduced, 
especially when elderly participants were 
assisted with using the technology. 
Asymptomatic participants with a his-
tory of a prior hip injury may have chosen 
not to participate in the study, citing that 
their hip was not normal. Although the 
authors chose to exclude participants with 
active hip disease, they did include par-
ticipants with a history of a previous hip 
problem that “no longer bothered them” 
(ie, asymptomatic). Because this is a pure-
ly subjective report, it is possible that some 
asymptomatic individuals with a prior hip 
problem and only minor functional inca-
pacities who could have been included 
self-excluded themselves.
The arthritic cohort was sourced from 
Australia, and from the same city as the 
asymptomatic Australian cohort. Although 
differences in PROM values in asymptom-
atic cohorts from 2 geographically distinct 
English-speaking Western countries were 
reported, no such comparisons could be 
made for the arthritic cohort. Therefore, 
future THA studies should involve com-
parison with a control group sourced from 
the same country of origin.
Because the main goal of this study 
was the establishment of an asymptomatic 
control group, longitudinal data were not 
collected over several time points; hence, 
response rate could not be assessed and 
the PROMs could not be validated. Valida-
tion, which requires collection of multiple 
data over different time points, was not 
within the scope of this study. Formal va-
lidity studies have not been published for 
English translations of the HOOS and the 
WOMAC. Future studies could collect the 
WOMAC and the HOOS values in both 
asymptomatic and arthritic cohorts on a 
longitudinal basis. However, this would re-
quire significant administration, resources, 
and personnel. A positive step toward this 
goal is the establishment of an electronic 
database of population reference values 
for various ages across the sexes for the 
HOOS and the WOMAC PROMs.
To the authors’ knowledge, this study 
represents the largest cohort of com-
bined asymptomatic and arthritic partici-
pants using the HOOS and the WOMAC 
PROMs. The authors aim to expand this 
database to include an arthritic popula-
tion of equivalent size with longitudinal 
data. The HOOS and the WOMAC are 
preferable in the development of a large 
electronic catalog of normal control popu-
lation data because they permit remote ad-
ministration. With resource management 
and cost justification becoming more of 
a focus in health care, PROMs that can 
be administered remotely make future 
research, especially international multi-
center cohort studies, a possibility.
conclusion
This observational study established 
an electronic HOOS and WOMAC PROM 
database of asymptomatic individuals in 2 
geographically distinct English-speaking 
countries for comparison with age- and 
sex-matched arthritic and THA patients. 
The HOOS should be used in prefer-
ence to the WOMAC when assessing for 
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variation in younger age groups (40 to 69 
years). An asymptomatic control group 
should ideally be sourced from the same 
country of origin as the proposed study. 
Factors that should be considered when 
recording the HOOS and the WOMAC in-
clude age, sex, geographic location, a his-
tory of an inactive (previous) hip problem, 
contralateral hip disease, and an active 
knee, ankle, or foot problem.
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